ࡱ> nqijklm^fbjbjqyy ,,!!!!!$!!!P"$=#$!Pa$a$a$a$a$%%%hjjjjjj$Q*-!%%%%%!!a$a$Hݣݣݣ%fd!a$!a$hݣ%hݣݣnXa$PR[uj T0-y-@XX\-!%%ݣ%%%%% %%%%%%%-%%%%%%%%%,? k : >40B>: 2 4> B5=45@=>W 4>:C<5=B0FVW $ &/   -"%', /! " ,!   % " !"  " # 70 :>4><  021:2015:33690000-3 - V:0@AL:V 70A>18 @V7=V 2V4?>2V4=89 :>4 CPV 70  021:2015:33696500-0 - 01>@0B>@=V @50:B828. .030;L=V 28<>38 1.">20@, 70?@>?>=>20=89 CG0A=8:>< ?@>F54C@8 70:C?V2;V, ?>28=5= 1CB8 =0;56=8< G8=>< 7045:;0@>20=89 (70@5TAB@>20=89) 2 #:@0W=V C ?5@5410G5=><C 70:>=>402AB2>< ?>@O4:C. 0 ?V4B25@465==O CG0A=8: ?>28=5= =040B8 :>?VN (W) 45:;0@0FV9 ?@> 2V4?>2V4=VABL 01> :>?VW V=H8E 4>:C<5=BV2, I> ?V4B25@46CNBL <>6;82VABL 22545==O 2 >1V3 B0/01> 5:A?;C0B0FVN (70AB>AC20==O) 70 @57C;LB0B0<8 ?@>E>465==O ?@>F54C@8 >FV=:8 2V4?>2V4=>ABV 73V4=> 28<>3 B5E=VG=>3> @53;0<5=BC =0 70?@>?>=>20=V <548G=V 28@>18 2V4?>2V4=> 4> 28<>3 ?>AB0=>2 01V=5BC V=VAB@V2 #:@0W=8 2V4 02.10.2013 ! 753 @> 70B25@465==O "5E=VG=>3> @53;0<5=BC I>4> <548G=8E 28@>1V2 B0 ! 754 @> 70B25@465==O "5E=VG=>3> @53;0<5=BC I>4> <548G=8E 28@>1V2 4;O 4V03=>AB8:8 in vitro. 2.>6;82VABL ?>AB02:8 B>20@C ?0@BVO<8, 01> ?>HBCG=>, 2V4?>2V4=> 4> ?>B@51 70<>2=8:0. 3."5@<V= ?@840B=>ABV =0 <><5=B ?>AB02:8 B>20@C ?>28=5= AB0=>28B8 =5 <5=H5 70% 2V4 7030;L=>3> B5@<V=C ?@840B=>ABV, 2AB0=>2;5=>3> 28@>1=8:><. 4.548:>-B5E=VG=V E0@0:B5@8AB8:8 B0 D>@<0 28?CA:C ?>28==V 2V4?>2V40B8 B0:V9, I> 2:070=0 2 B5=45@=V9 4>:C<5=B0FVW. 5.  <5B>N 70?>1V30==O 70:C?V2;V D0;LA8DV:0BV2 B0 4>B@8<0==O 30@0=BV9 =0 A2>TG0A=5 ?>AB0G0==O B>20@C C :V;L:>ABV, O:>ABV B0 7V AB@>:0<8 ?@840B=>ABV, CG0A=8: =040T >@83V=0; 30@0=BV9=>3> ;8AB0 28@>1=8:0 (?@54AB02=8FB20, DV;VW 28@>1=8:0, O:I> WE 2V4?>2V4=> ?>2=>2065==O ?>H8@NNBLAO =0 B5@8B>@VN #:@0W=8) 01> ?@54AB02=8:0, 48;5@0, 48AB@81 NB>@0 C?>2=>2065=>3> =0 F5 28@>1=8:><, O:8< ?V4B25@46CTBLAO <>6;82VABL ?>AB02:8 B>20@C, O:89 T ?@54<5B>< 70:C?V2;V F8E B>@3V2 B0 ?@>?>=CTBLAO CG0A=8:><, C :V;L:>ABV, 7V AB@>:0<8 ?@840B=>ABV B0 2 B5@<V=8, 287=0G5=V B5=45@=>N 4>:C<5=B0FVTN B0 ?@>?>78FVTN CG0A=8:0 B>@3V2. 0@0=BV9=89 ;8AB ?>28=5= 2:;NG0B8 V45=B8DV:0B>@ 70:C?V2;V (=><5@ >3>;>H5==O ?@> ?@>2545==O), >?@8;N4=5=>3> =0 251-?>@B0;V #?>2=>2065=>3> >@30=C, 0 B0:>6 =072C ?@54<5BC 70:C?V2;V B0 =072C 70<>2=8:0 73V4=> >3>;>H5==O. 6. ">20@ ?>28=5= ?>AB0G0B8AO A8;0<8, B@0=A?>@B><, I> 70157?5GCT O:VABL V 715@V30==O B>20@C ?@8 B@0=A?>@BC20==V, 7 9>3> @>720=B065==O< 70 <VAF5< ?>AB02:8 B>20@C, B0 70 @0EC=>: CG0A=8:0. 7.&V=0 =0 B>20@ ?>28==0 2@0E>2C20B8 CAV ?>40B:8 V 71>@8, I> A?;0GCNBLAO 01> <0NBL 1CB8 A?;0G5=V AB>A>2=> 70?@>?>=>20=>3> B>20@C, 28B@0B8 =0 B@0=A?>@BC20==O, =020=B065==O, @>720=B065==O, CAV V=HV 28B@0B8, 7 C@0EC20==O< =>@< G8==>3> 70:>=>402AB20 #:@0W=8 7 ?8B0=L D>@<C20==O FV=8 =0 28@>18 <548G=>3> ?@87=0G5==O. 8. "0@0 B0 C?0:>2:0 B>20@C ?>28==0 2V4?>2V40B8 28<>30< 2AB0=>2;5=8< 4> 40=>3> 284C B>20@C V 70E8I0B8 9>3> 2V4 ?>H:>465=L 01> ?AC20==O ?V4 G0A ?5@52575==O (4>AB02:8). #G0A=8: ?@>F54C@8 70:C?V2;V ?>28=5= =040B8 C A:;04V B5=45@=>W ?@>?>78FVW: 30@0=BV9=89 ;8AB, A:;045=89 C 4>2V;L=V9 D>@<V, ?@> <>6;82VABL 4>B@8<0==O 7030;L=8E 28<>3, 707=0G5=8E C ?C=:B0E 1,2,3,4,6,7,8 @>74V;C  FL>3> 4>40B:0 4> B5=45@=>W 4>:C<5=B0FVW; >@83V=0; 30@0=BV9=>3> ;8AB0 28@>1=8:0 (?@54AB02=8FB20, DV;VW 28@>1=8:0, O:I> WE 2V4?>2V4=> ?>2=>2065==O ?>H8@NNBLAO =0 B5@8B>@VN #:@0W=8) 01> ?@54AB02=8:0, 48;5@0, 48AB@81 NB>@0 C?>2=>2065=>3> =0 F5 28@>1=8:><, O:8< ?V4B25@46CTBLAO <>6;82VABL ?>AB02:8 B>20@C, 2V4?>2V4=> ?.5 @>74V;C  FL>3> 4>40B:0 4> B5=45@=>W 4>:C<5=B0FVW. ."5E=VG=0 A?5F8DV:0FVO #G0A=8: ?@>F54C@8 70:C?V2;V ?>28=5= =040B8 C A:;04V B5=45@=>W ?@>?>78FVW B01;8FN 2V4?>2V4=>ABV 70?@>?>=>20=>3> B>20@C <548:>-B5E=VG=8< E0@0:B5@8AB8:0< 73V4=> C<>2 @>74V;C  FL>3> 4>40B:0 4> B5=45@=>W 4>:C<5=B0FVW V7 707=0G5==O< C 3@0DV 2 B01;8FV =09<5=C20==O 70?@>?>=>20=>3> B>20@C 73V4=> 4>:C<5=BV2 28@>1=8:0, B0 ?V4B25@465==O< 2V4?>2V4=>ABV B>20@C <548:>-B5E=VG=8< E0@0:B5@8AB8:0< (707=0G8B8 B0: G8 =V) C 3@0DV 7 B01;8FV. ! 7/?0720>4   024:2023"5E=VG=V 28<>38 48=8FO 28<V@CV;L:VABLV4?>2V4=VABL "0:\=V 12345671<C=>B5AB 4;O :V;L:VA=>3> 287=0G5==O :0@F8=>5<1@V>=0;L=>3> 0=B835=C / CEA54615 - 0:>2>-5<1@V>=0;L=89 0=B835= IVD (4V03=>AB8:0 in vitro ), =01V@, V<C=>E5<V;N<V=5AF5=B=89 0=0;V7 ;O 0=0;V70B>@0 cobas e 411, 100 B5ABV2 V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=>< (?@>7>@89 :>2?0G>:), 1 D;0:>=, 8 <;: V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=><, 0.72 <3/<;; :>=A5@20=B. R1 =B8BV;> 4> 0=B835=0 ~1V>B8= (AV@89 :>2?0G>:), 1 D;0:>=,10 <;: V>B8=V;L>20=5 <>=>:;>=0;L=5 0=B8BV;> 4> 0=B835=0  (<8H0G5/;N4AL:5) 3.0 <3/;; D>AD0B=89 1CD5@ 100 <<>;L/;, @ 6.0; :>=A5@20=B. R2 =B8BV;> 4> 0=B835=0 ~Ru(bpy) (G>@=89 :>2?0G>:), 1 D;0:>=, 8 <;: >=>:;>=0;L=5 0=B8BV;> 4> 0=B835=0  (<8H0G5), <VG5=5 :><?;5:A>< @CB5=VN, 4.0 <3/;; D>AD0B=89 1CD5@ 100 <<>;L/;, @ 6.5; :>=A5@20=B.HB120;V1@C20;L=89 =01V@ 4;O B5ABC CEA38174 - 0:>2>-5<1@V>=0;L=89 0=B835= IVD (4V03=>AB8:0 in vitro ), :0;V1@0B>@;O 0=0;V70B>@0 cobas e 411 4 x 1 <; (ml) CEA Cal1: 2 D;0:>=8, ?> 1.0 <; :0;V1@0B>@0 1 CEA Cal2: 2 D;0:>=8, ?> 1.0 <; :0;V1@0B>@0 2  (;N4AL:89, 7 :C;LBC@8 :;VB8=) C 42>E 4V0?07>=0E :>=F5=B@0FV9 (?@81;87=> 5 =3/<; B0 ?@81;87=> 50 =3/<;) C 1CD5@V/1V;:>2V9 <0B@8FV. 1 =3/<;  2V4?>2V40T 16.9 </<;.=01V@13"5AB 4;O 287=0G5==O @0:>2>3> 0=B835=C 125 II54588 - 0:>289 0=B835= 125 (!125) IVD (4V03=>AB8:0 in vitro ), =01V@, V<C=>E5<V;N<V=5AF5=B=89 0=0;V7 ;O 0=0;V70B>@0 cobas e 411 100 B5ABV2 (B0B82 4;O @50:B82V2 <0T <0@:C20==O CA 125 II. M V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=>< (?@>7>@0 :@8H:0), 1 D;0:>=, 6.5 <;: V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=><, 0.72 <3/<;; :>=A5@20=B. R1 =B8-CA 125-0=B8BV;>~1V>B8= (AV@89 :>2?0G>:), 1 D;0:>=, 9 <;: V>B8=V;L>20=V <>=>:;>=0;L=V 0=B8BV;0 4> CA 125 (M 11; <8H0GV) 1 <3/;, D>AD0B=89 1CD5@ 100 <<>;L/;, pH 7.4; :>=A5@20=B. R2 =B8BV;0 4> CA 125~Ru(bpy) (G>@=0 :@8H:0), 1 D;0:>=, 9 <;: >=>:;>=0;L=V 0=B8BV;0 4> CA 125 (OC 125; <8H0GV), <VG5=V :><?;5:A>< @CB5=VN 1 <3/;; D>AD0B=89 1CD5@ 100 <<>;L/;, pH 7.4; :>=A5@20=B.HB440;V1@C20;L=89 =01V@ 4;O B5ABC 4;O 287=0G5==O @0:>2>3> 0=B835=C 125 II38231 - 0:>289 0=B835= 125 (!125) IVD (4V03=>AB8:0 in vitro ), :0;i1@0B>@;O 0=0;V70B>@0 cobas e 411 4 x 1 <; (ml) CA125 II Cal1: 2 D;0:>=8, ?> 1.0 <; :0;V1@0B>@0 1 CA125 II Cal2: 2 D;0:>=8, ?> 1.0 <; :0;V1@0B>@0 2 >=F5=B@0FVO ;N4AL:>3> CA 125 C <0B@8FV :>=OG>W A8@>20B:8 (CA125 II Cal1) AB0=>28BL 0 /<;; CA125 II Cal2 <VAB8BL ?@81;87=> 500 /<; ;N4AL:>3> CA 125 C <0B@8FV A8@>20B:8 :@>2V ;N48=8; :>=A5@20=B.=01V@25<C=>B5AB 4;O :V;L:VA=>3> 287=0G5==O HE456656 - V;>: 4 5?V4848<VA0 ;N48=8 (HE4) IVD (4V03=>AB8:0 in vitro ), =01V@, V<C=>E5<V;N<V=5AF5=B=89 0=0;V7 ;O 0=0;V70B>@0 cobas e 411 100 B5ABV2 (B0B82 4;O @50:B82V2 <0T <0@:C20==O HE4. M V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=>< (?@>7>@89 :>2?0G>:), 1 D;0:>=, 6.5 <;: V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=><, 0.72 <3/<;; :>=A5@20=B. R1 =B8BV;> 4> 0=B835=C HE4~1V>B8= (AV@89 :>2?0G>:), 1 D;0:>=, 10 <;: V>B8=V;L>20=5 <>=>:;>=0;L=5 0=B8BV;> 4> 0=B835=C HE4 (<8H0G5) 0.75 <3/;; D>AD0B=89 1CD5@ 100 <<>;L/;, pH 6.5; :>=A5@20=B. R2 =B8BV;> 4> 0=B835=C HE4~Ru(bpy) (G>@=89 :>2?0G>:), 1 D;0:>=, 10 <;: >=>:;>=0;L=5 0=B8BV;> 4> 0=B835=C HE4 (<8H0G5), <VG5=5 :><?;5:A>< @CB5=VN, 1.5 <3/;; D>AD0B=89 1CD5@ 100 <<>;L/;, @ 7.4; :>=A5@20=B.HB460;V1@C20;L=89 =01V@ 4;O B5ABC HE456658 - V;>: 4 5?V4848<VA0 ;N48=8 (HE4) IVD (4V03=>AB8:0 in vitro ), :0;V1@0B>@;O 0=0;V70B>@0 cobas e 411 4 x 1 <; (ml) HE4 Cal1: 2 D;0:>=8, ?> 1.0 <; :0;V1@0B>@0 1 HE4 Cal2: 2 D;0:>=8, ?> 1.0 <; :0;V1@0B>@0 2 HE4 (;N4AL:89, 7 :;VB8==>W ;V=VW OvCar 3) C 42>E 4V0?07>=0E :>=F5=B@0FV9 (?@81;87=> 5 ?<>;L/; B0 ?@81;87=> 200 ?<>;L/;) C <0B@8FV :>=OG>W A8@>20B:8; :>=A5@20=B.=01V@27"5AB 4;O :V;L:VA=>3> 287=0G5==O @0:>2>3> 0=B835=C 15-3 /CA 15-3 II Cancer Antigen 15-360975 - 0:>289 0=B835= 15-3 (CA15-3) IVD (4V03=>AB8:0 in vitro ), =01V@, V<C=>E5<V;N<V=5AF5=B=89 0=0;V7;O 0=0;V70B>@0 cobas e 411 100 B5ABV2 (B0B82 4;O @50:B82V2 <0T <0@:C20==O CA 153 II. M V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=>< (?@>7>@89 :>2?0G>:), 1 D;0:>=, 6.5 <;: V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=><, 0.72 <3/<;; :>=A5@20=B. R1 =B8BV;0 4> 0=B835=C CA 15-3~1V>B8= (AV@89 :>2?0G>:), 1 D;0:>=, 10 <;: V>B8=V;L>20=5 <>=>:;>=0;L=5 0=B8BV;> (115D8; <8H0G5) 1.75 <3/;; D>AD0B=89 1CD5@ 20 <<>;L/;, pH 6.0; :>=A5@20=B. R2 =B8BV;0 4> 0=B835=C CA 15-3~Ru(bpy) (G>@=89 :>2?0G>:), 1 D;0:>=, 10 <;: >=>:;>=0;L=5 0=B8BV;> 4> 0=B835=C CA 15-3 (DF3; <8H0G5), <VG5=5 :><?;5:A>< @CB5=VN 10 <3/;; D>AD0B=89 1CD5@ 100 <<>;L/;, pH 7.0; :>=A5@20=B.HB480;V1@C20;L=89 =01V@ 4;O B5ABC CA 15-3 II /CA 15-3 II CalSet38223 - 0:>289 0=B835= 15-3 (!15-3) IVD (4V03=>AB8:0 in vitro ), :0;i1@0B>@;O 0=0;V70B>@0 cobas e 411 4 x 1.0 <; CA 153 II Cal1: 2 D;0:>=8, ?> 1.0 <; :0;V1@0B>@0 1 % CA 153 II Cal2: 2 D;0:>=8, ?> 1.0 <; :0;V1@0B>@0 2 CA 153 (;N48=8) C 42>E 4V0?07>=0E :>=F5=B@0FV9 (?@81;87=> 15 /<; B0 ?@81;87=> 100 /<;) C <0B@8FV A8@>20B:8 :@>2V ;N48=8.=01V@2901V@ :>=B@>;L=8E A8@>20B>: PreciControl 4;O 287=0G5==O >=:><0@:5@V238220 - =>68==V B:0=8=>A?5F8DVGV 1V;:8/?CE;8==V <0@:5@8 IVD (4V03=>AB8:0 in vitro ), :>=B@>;L=89;O 0=0;V70B>@0 cobas e 411 4 E 3 <; (ml) PC TM1: 2 D;0:>=8, ?> 3.0 <; :>=B@>;L=>W A8@>20B:8 (;N4AL:>W) PC TM2: 2 D;0:>=8, ?> 3.0 <; :>=B@>;L=>W A8@>20B:8 (;N4AL:>W)=01V@210<C=>0=0;V7 4;O :V;L:VA=>3> 287=0G5==O B8@>:A8=C, cobas e58322 - 030;L=89 B8@>:A8= (""4) IVD (4V03=>AB8:0 in vitro ), =01V@, V<C=>E5<V;N<V=5AF5=B=89 0=0;V7 ;O 0=0;V70B>@0 cobas e 411 200 B5ABV2 (B0B82 4;O @50:B82V2 <0T <0@:C20==O T4.M V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=>< (?@>7>@89 :>2?0G>:), 1 D;0:>=, 12 <;:  V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=>< 0.72 <3/<;; :>=A5@20=B. R1 =B8BV;0 4> T4~Ru(bpy) (AV@89 :>2?0G>:), 1 D;0:>=, 18 <;: >;V:;>=0;L=5 0=B8BV;> 4> T4 (>25G5), <VG5=5 :><?;5:A>< @CB5=VN, 100 =3/<;; ! 1 <3/<;; D>AD0B=89 1CD5@ 100 <<>;L/;, pH 7.4; :>=A5@20=B. R2 T4~1V>B8= (G>@=89 :>2?0G>:), 1 D;0:>=, 18 <;: V>B8=V;L>20=89 T4 20 =3/<;; D>AD0B=89 1CD5@ 100 <<>;L/;, pH 7.4; :>=A5@20=BHB4110;V1@C20;L=89 =01V@ 4;O B5ABC T458324 - 030;L=89 B8@>:A8= (""4) IVD (4V03=>AB8:0 in vitro ), :0;V1@0B>@ ;O 0=0;V70B>@0 cobas e 411 4 x 1 <; (ml) T4 Cal1: 2 D;0:>=8, :>65= ?> 1.0 <; :0;V1@0B>@0 1 T4 Cal2: 2 D;0:>=8, :>65= ?> 1.0 <; :0;V1@0B>@0 2 L B8@>:A8= C 42>E 4V0?07>=0E :>=F5=B@0FV9 (1;87L:> 50 =<>;L/; 01> 3.9 <:3/4; B0 1;87L:> 230 =<>;L/; 01> 17.9 <:3/4;) 2 1CD5@=V9/1V;:>2V9 (18G0G89 A8@>20B:>289 0;L1C<V=) <0B@8FV=01V@212<C=>B5AB 4;O :V;L:VA=>3> 287=0G5==O =572'O70=>3> B8@>:A8=C, gen.III54413 - V;L=89 B8@>:A8= IVD (4V03=>AB8:0 in vitro ), =01V@, V<C=>E5<V;N<V=5AF5=B=89 0=0;V7;O 0=0;V70B>@0 cobas e 411 200 B5ABV2 (B0B82 4;O @50:B82V2 <0T <0@:C20==O FT4 III. M V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=>< (?@>7>@89 :>2?0G>:), 1 D;0:>=, 12 <;: V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=><, 0.72 <3/<;; :>=A5@20=B. R1 =B8BV;> 4> 0=B835=0 T4~Ru(bpy) ,(AV@0 :@8H:0) 1 D;0:>=, 18 <;: >=>:;>=0;L=5 0=B8BV;> 4> 0=B835=0 T4 (>25G5), <VG5=5 :><?;5:A>< @CB5=VN, 75 =3/<;; D>AD0B=89 1CD5@ 100 <<>;L/;, pH 7.0; :>=A5@20=B. R2 T4~1V>B8= (G>@=89 :>2?0G>:), 1 D;0:>=, 18 <;: V>B8=V;L>20=89 T4 2.5 =3/<;; D>AD0B=89 1CD5@ 100 <<>;L/;, pH 7.0; :>=A5@20=B.HB41301V@ 4;O :0;V1@C20==O V<C=>B5ABC Elecsys FT4 , 4 E 1.0 <;38259 - V;L=89 B8@>:A8= IVD (4V03=>AB8:0 in vitro), :0;i1@0B>@;O 0=0;V70B>@0 cobas e 411 4 x 1 <; (ml) FT4 III Cal1: 2 D;0:>=8, ?> 1.0 <; :0;V1@0B>@0 1 FT4 III Cal2: 2 D;0:>=8, ?> 1.0 <; :0;V1@0B>@0 2 52>B8@>:A8= C 42>E 4V0?07>=0E :>=F5=B@0FV9 (?@81;87=> 10 ?<>;L/; 01> 0.78 =3/4;, B0 45 ?<>;L/;, 01> 3.5 =3/4;) 2 1CD5@=V9/1V;:>2V9 (0;L1C<V= 18G0G>W A8@>20B:8) <0B@8FV.=01V@214"5AB-A8AB5<0 4;O 287=0G5==O B8@5>B@>?=>3> 3>@<>=C 2 35=.54386 - "8@5>W4=89 3>@<>= ("") IVD (4V03=>AB8:0 in vitro ), =01V@, V<C=>E5<V;N<V=5AF5=B=89 0=0;V77;O 0=0;V70B>@0 cobas e 411 200 B5ABV2 (B0B82 4;O @50:B82V2 <0T <0@:C20==O TSH. M V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=>< (?@>7>@89 :>2?0G>:), 1 D;0:>=, 12 <;: V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=><, 0.72 <3/<;; :>=A5@20=B R1 =B8BV;0 4> ""~1V>B8= (AV@89 :>2?0G>:), 1 D;0:>=, 14 <;: V>B8=V;L>20=5 <>=>:;>=0;L=5 0=B8BV;> 4> "" (<8H0G5) 2.0 <3/;; D>AD0B=89 1CD5@ 100 <<>;L/;, pH 7.2; :>=A5@20=B. R2 =B8BV;0 4> ""~Ru(bpy) (G>@=89 :>2?0G>:), 1 D;0:>=, 12 <;: >=>:;>=0;L=5 0=B8BV;> 4> "" (<8H0G5/;N4AL:5), <VG5=5 :><?;5:A>< @CB5=VN, 1.5 <3/;; D>AD0B=89 1CD5@ 100 <<>;L/;, pH 7.2; :>=A5@20=B.HB4150;V1@0FV9=89 =01V@ TSH 38272 - "8@5>B@>?=89 3>@<>= ("") IVD (4V03=>AB8:0 in vitro ), :0;i1@0B>@;O 0=0;V70B>@0 cobas e 411 4 x 1.3 <; (ml) TSH Cal1: 2 D;0:>=8, ?> 1.3 <; :0;V1@0B>@0 1 TSH Cal2: 2 D;0:>=8, ?> 1.3 <; :0;V1@0B>@0 2 >=F5=B@0FVO TSH Cal1 C <0B@8FV :>=OG>W A8@>20B:8 AB0=>28BL ?@81;87=> 0 <:/<;; TSH Cal2 <VAB8BL ?@81;87=> 1.5 <:/<; "" (;N48=8) C <0B@8FV A8@>20B:8 :@>2V ;N48=8.=01V@216<C=>B5AB 4;O :V;L:VA=>3> 287=0G5==O 0=B8BV; 4> B8@5>?5@>:A84078, 25@. 3 /Anti-TPO Gen.358729 - "8@5>?5@>:A84070, 0=B8BV;0 (0=B8-", <V:@>A><0;L=V 0=B8BV;0) IVD (4V03=>AB8:0 in vitro ), =01V@, V<C=>E5<V;N<V=5AF5=B=89 0=0;V7 ;O 0=0;V70B>@0 cobas e 411 100 B5ABV2 (B0B82 7 @50:B820<8 <0T <0@:C20==O A TPO. M V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=>< (?@>7>@89 :>2?0G>:), 1 D;0:>=, 6.5 <;: V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=><, 0.72 <3/<;; :>=A5@20=B. R1 =B8BV;0 4> "~Ru(bpy) (AV@89 :>2?0G>:), 1 D;0:>=, 9 <;: >;V:;>=0;L=5 0=B8BV;> 4> 0=B835=C TO (>25G5), <VG5=5 :><?;5:A>< @CB5=VN, 1.0 <3/;; 1CD5@ TRIS 100 <<>;L/;, pH 7.2; :>=A5@20=B. R2 "~1V>B8= (G>@=89 :>2?0G>:), 1 D;0:>=, 9 <;: V>B8=V;L>20=0 " (@5:><1V=0=B=0) 0.15 <3/;; 1CD5@ TRIS 30 <<>;L/;, pH 7.0; :>=A5@20=B.HB8170;V1@C20;L=89 =01V@ 4;O B5ABC Anti-TPO55210 - "8@5>3;>1C;V=/ B8@5>?5@>:A84070, 0=B8BV;0 (0=B8- "/<V:@>A><0;L=V 0=B8BV;0) IVD (4V03=>AB8:0 in vitro ), :0;V1@0B>@ ;O 0=0;V70B>@0 cobas e 411 4 x 1,5 <; (ml) Anti TPO Cal1: 2 D;0:>=8 ?> 1.5 <; :0;V1@0B>@0 1 Anti TPO Cal2: 2 D;0:>=8 ?> 1.5 <; :0;V1@0B>@0 2 =B8BV;0 " (>25GV) C 42>E 4V0?07>=0E :>=F5=B@0FV9 (?@81;87=> 35 /<; B0 ?@81;87=> 350 /<;) C <0B@8FV A8@>20B:8 :@>2V ;N48=8.=01V@218<C=>0=0;V7 4;O :V;L:VA=>3> 287=0G5==O D>;V:C;>AB8<C;NNG>3> 3>@<>=C, cobas e 411/601/60254187 - $>;V:C;>AB8<C;N20;L=89 3>@<>= ($!) IVD (4V03=>AB8:0 in vitro ), =01V@, V<C=>E5<V;N<V=5AF5=B=89 0=0;V7;O 0=0;V70B>@0 cobas e 411 100 B5ABV2 (B0B82 4;O @50:B82V2 <0T <0@:C20==O FSH. M V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=>< (?@>7>@0 :@8H:0), 1 D;0:>=, 6.5 <;: V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=><, 0.72 <3/<;; :>=A5@20=B. R1 =B8BV;0 4> 0=B835=0 $!~1V>B8= (AV@0 :@8H:0), 1 D;0:>=, 10 <;: V>B8=V;L>20=5 <>=>:;>=0;L=5 0=B8BV;> 4> 0=B835=0 $! (<8H0G5) 0.5 <3/;; 1CD5@ ! 50 <<>;L/;, @ 6.0; :>=A5@20=B. R2 =B8BV;0 4> 0=B835=0 $!~Ru(bpy) (G>@=0 :@8H:0), 1 D;0:>=, 10 <;: >=>:;>=0;L=5 0=B8BV;> 4> 0=B835=0 $! (<8H0G5), <VG5=5 :><?;5:A>< @CB5=VN, 0.8 <3/;; 1CD5@ ! 50 <<>;L/;, pH 6.0; :>=A5@20=B.HB51901V@ 4;O :0;V1@C20==O :V;L:VA=>3> B5ABC Elecsys FSH38255 - $>;V:C;>AB8<C;N20;L=89 3>@<>= IVD (4V03=>AB8:0 in vitro ), :0;i1@0B>@;O 0=0;V70B>@0 cobas e 411 4 x1.0 <; FSH Cal1: 2 D;0:>=8, ?> 1.0 <; :0;V1@0B>@0 1 FSH Cal2: 2 D;0:>=8, ?> 1.0 <; :0;V1@0B>@0 2 $! (;N4AL:89) C 42>E 4V0?07>=0E :>=F5=B@0FV9 (?@81;87=> 1 </<; V ?@81;87=> 55 </<;) C <0B@8FV :>=OG>W A8@>20B:8.=01V@220<C=>B5AB 4;O :V;L:VA=>3> 287=0G5==O ;NB5W=V7CNG>3> 3>@<>=C / LH54254 - NB5W=V7C20;L=89 3>@<>= IVD (4V03=>AB8:0 in vitro ), =01V@, V<C=>E5<V;N<V=5AF5=B=89 0=0;V7;O 0=0;V70B>@0 cobas e 411 100 B5ABV2 (B0B82 4;O @50:B82V2 <0T <0@:C20==O . M V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=>< (?@>7>@0 :@8H:0), 1 D;0:>=, 6.5 <;: V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=><, 0.72 <3/<;; :>=A5@20=B. R1 =B8BV;0 4> 0=B835=0 ~1V>B8= (AV@0 :@8H:0), 1 D;0:>=, 10 <;: V>B8=V;L>20=5 <>=>:;>=0;L=5 0=B8BV;> 4> 0=B835=0  (<8H0G5) 2.0 <3/;; 1CD5@ TRIS 50 <<>;L/;; @ 8.0; :>=A5@20=B. R2 =B8BV;0 4> 0=B835=0 ~Ru(bpy) (G>@=0 :@8H:0), 1 D;0:>=, 10 <;: >=>:;>=0;L=5 0=B8BV;> 4> 0=B835=0  (<8H0G5), <VG5=5 :><?;5:A>< @CB5=VN, 0.3 <3/;; 1CD5@ TRIS 50 <<>;L/;, pH 8.0; :>=A5@20=B.HB5210;V1@C20;L=89 =01V@ 4;O :V;L:VA=>3> 0=0;V7C Elecsys LH /LH CS Gen.238270 - NB5W=V7C20;L=89 3>@<>= IVD (4V03=>AB8:0 in vitro ), :0;V1@0B>@;O 0=0;V70B>@0 cobas e 411 4 x 1 <; (ml) LH Cal1: 2 D;0:>=8, ?> 1.0 <; :0;V1@0B>@0 1 2 :>6=><C LH Cal2: 2 D;0:>=8, ?> 1.0 <; :0;V1@0B>@0 2 2 :>6=><C  ;N48=8 C 42>E 4V0?07>=0E :>=F5=B@0FV9 (?@81;87=> 1 </<; B0 ?@81;87=> 45 </<;) C <0B@8:AV A8@>20B:8 :@>2V ;N48=8.=01V@222<C=>B5AB 4;O :V;L:VA=>3> 287=0G5==O ?@>35AB5@>=C /Progesterone III54322 - @>35AB5@>= IVD (4V03=>AB8:0 in vitro ), =01V@, V<C=>E5<V;N<V=5AF5=B=89 0=0;V7;O 0=0;V70B>@0 cobas e 411 100 B5ABV2 (B0B82 4;O @50:B82V2 <0T <0@:C20==O PROG III. M V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=>< (?@>7>@0 :@8H:0), 1 D;0:>=, 6.5 <;: V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=><, 0.72 <3/<;; :>=A5@20=B R1 =B8BV;0 4> ?@>35AB5@>=C~1V>B8= (AV@0 :@8H:0), 1 D;0:>=, 10 <;: V>B8=V;L>20=5 <>=>:;>=0;L=5 0=B8BV;> 4> 0=B835=0 @>35AB5@>= (@5:><1V=0=B=5, >25G5) 30 =3/<;; D>AD0B=89 1CD5@ 25 <<>;L/;, @ 7.0; :>=A5@20=B. R2 >@B87>;-?5?B84~Ru(bpy) (G>@=89 :>2?0G>:), 1 D;0:>=, 9 <;: @>35AB5@>= (@>A;8==>3> ?>E>465==O) 72 O7CTBLAO V7 A8=B5B8G=8< ?5?B84><, <VG5=8< :><?;5:A>< @CB5=VN 2 =3/<;; D>AD0B=89 1CD5@ 25 <<>;L/;, @ 7.0; :>=A5@20=B.HB7230;V1@0B>@ 4;O Progesterone III / Progesterone III CalSet54325 - @>35AB5@>= IVD (4V03=>AB8:0 in vitro ), :0;V1@0B>@;O 0=0;V70B>@0 cobas e 411 4 x 1 <; (ml) PROG III Cal1: 2 D;0:>=8, ?> 1.0 <; :0;V1@0B>@0 1 PROG III Cal2: 2 D;0:>=8, ?> 1.0 <; :0;V1@0B>@0 2 @>35AB5@>= (7 @>A;8==>W A8@>28=8) C 42>E 4V0?07>=0E :>=F5=B@0FV9 (?@81;87=> 0.6 =<>;L/; 01> 0.2 =3/<; V ?@81;87=> 169 =<>;L/; 01> 53 =3/<;) C ;N4AL:V9 A8@>20B:>2V9 <0B@8FV.=01V@224<C=>0=0;V7 4;O :V;L:VA=>3> 287=0G5==O B5AB>AB5@>=C, cobas e 411/601/60261077 - 030;L=89 B5AB>AB5@>= IVD (4V03=>AB8:0 in vitro ), =01V@, V<C=>E5<V;N<V=5AF5=B=89 0=0;V7 ;O 0=0;V70B>@0 cobas e 411 100 B5ABV2 PROG III Cal1: 2 D;0:>=8, ?> 1.0 <; :0;V1@0B>@0 1 PROG III Cal2: 2 D;0:>=8, ?> 1.0 <; :0;V1@0B>@0 2 @>35AB5@>= (7 @>A;8==>W A8@>28=8) C 42>E 4V0?07>=0E :>=F5=B@0FV9 (?@81;87=> 0.6 =<>;L/; 01> 0.2 =3/<; V ?@81;87=> 169 <>;L/; 01> 53 =3/<;) C ;N4AL:V9 A8@>20B:>2V9 <0B@8FV. R1 =B8BV;> 4> B5AB>AB5@>=C~1V>B8= (AV@89 :>2?0G>:), 1 D;0:>=, 10 <;: V>B8=V;L>20=5 <>=>:;>=0;L=5 0=B8BV;> 4> B5AB>AB5@>=C (>25G5) 40 =3/<;; 282V;L=ONG89 @50:B82 2-1@><>5AB@04V>;; MES-1CD5@ 50 <<>;L/;, pH 6.0; :>=A5@20=B. R2 "5AB>AB5@>=-?5?B84~Ru(bpy) (G>@=89 :>2?0G>:), 1 D;0:>=, 9 <;: >EV4=89 B5AB>AB5@>=C, <VG5=89 :><?;5:A>< @CB5=VN 1.5 =3/<;; MES-1CD5@ 50 <<>;L/;, pH 6.0; :>=A5@20=B.HB5250;V1@C20;L=89 =01V@ 4;O 0=0;V7C Testosterone Gen.258381 -030;L=89 B5AB>AB5@>= IVD (4V03=>AB8:0 in vitro ), :0;V1@0B>@;O 0=0;V70B>@0 cobas e 411 4 x 1 <; (ml) TESTO Cal1: 2 D;0:>=8, ?> 1.0 <; :0;V1@0B>@0 1 TESTO Cal2: 2 D;0:>=8, ?> 1.0 <; :0;V1@0B>@0 2 "5AB>AB5@>= (@>A;8==89 <0B5@V0;) C 42>E 4V0?07>=0E :>=F5=B@0FV9 (?@81;87=> 0.4 =3/<; 01> 40 =3/4; 01> 1.4 =<>;L/; B0 ?@81;87=> 11.5 =3/<; 01> 1150 =3/4; 01> 40 =<>;L/;) C <0B@8FV A8@>20B:8 :@>2V ;N48=8.=01V@226"5AB 4;O 287=0G5==O 5AB@04V>;C III60979 - AB@04V>; IVD (4V03=>AB8:0 in vitro ), =01V@, V<C=>E5<V;N<V=5AF5=B=89 0=0;V7;O 0=0;V70B>@0 cobas e 411 100 B5ABV2 M V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=>< (?@>7>@89 :>2?0G>:), 1 D;0:>=, 6.5 <;: V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=><, 0.72 <3/<;; :>=A5@20=B. R1 =B8BV;> 4> 0=B835=0 5AB@04V>;C~1V>B8= (AV@89 :>2?0G>:), 1 D;0:>=, 9 <;: 20 1V>B8=V;L>20=8E <>=>:;>=0;L=8E 0=B8BV;0 4> 0=B835=0 5AB@04V>;C (:@>;OGV) 2.5 =3/<; B0 4.5 =3/<;; <5AB5@>;>= 130 =3/<;; (B0B82 4;O @50:B82V2 <0T <0@:C20==O E2 III. 1CD5@ ME!b) 50 <<>;L/;, pH 6.0; :>=A5@20=B. R2 AB@04V>; ?5?B84~Ru(bpy) (G>@=89 :>2?0G>:), 1 D;0:>=, 9 <;: >EV4=89 5AB@04V>;C, <VG5=89 :><?;5:A>< @CB5=VN, 4.5 =3/<;; 1CD5@ ME! 50 <<>;L/;, pH 6.0; :>=A5@20=B.HB5270;V1@C20;L=89 =01V@ 4;O B5ABC 4;O 287=0G5==O 5AB@04V>;C III38249 - AB@04V>; IVD (4V03=>AB8:0 in vitro ), :0;i1@0B>@;O 0=0;V70B>@0 cobas e 411 4 x 1 <; (ml) E2 III Cal1: 2 D;0:>=8, ?> 1.0 <; :0;V1@0B>@0 1 E2 III Cal2: 2 D;0:>=8, ?> 1.0 <; :0;V1@0B>@0 2 AB@04V>; (A8=B5B8G=89) C 42>E 4V0?07>=0E :>=F5=B@0FV9 (?@81;87=> 73 ?<>;L/; 01> 20 ?3/<; V ?@81;87=> 7340 ?<>;L/; 01> 2000 ?3/<;) C <0B@8FV A8@>20B:8 :@>2V ;N48=8; :>=A5@20=B=01V@228"5AB 4;O :V;L:VA=>3> 287=0G5==O ?@>;0:B8=C /Prolactin 54335 - @>;0:B8= IVD (4V03=>AB8:0 in vitro ), =01V@, V<C=>E5<V;N<V=5AF5=B=89 0=0;V7;O 0=0;V70B>@0 cobas e 411 100 B5ABV2 (B0B82 4;O @50:B82V2 <0T <0@:C20==O PRL II. M V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=>< (?@>7>@89 :>2?0G>:), 1 D;0:>=, 6.5 <;: V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=><, 0.72 <3/<;; :>=A5@20=B. R1 =B8BV;> 4> 0=B835=V2 ?@>;0:B8=C~1V>B8= (AV@89 :>2?0G>:), 1 D;0:>=, 10 <;: V>B8=V;L>20=5 <>=>:;>=0;L=5 0=B8BV;> 4> 0=B835=V2 ?@>;0:B8=C (<8H0G5) 0.7 <3/;; D>AD0B=89 1CD5@ 50 <<>;L/;, pH 7.0; :>=A5@20=B. R2 =B8BV;> 4> 0=B835=V2 ?@>;0:B8=C~Ru(bpy) (G>@=89 :>2?0G>:), 1 D;0:>=, 10 <;: >=>:;>=0;L=5 0=B8BV;> 4> 0=B835=V2 ?@>;0:B8=C (<8H0G5), <VG5=5 :><?;5:A>< @CB5=VN 0.35 <3/;; D>AD0B=89 1CD5@ 50 <<>;L/;, pH 7.0; :>=A5@20=B.HB7290;V1@C20;L=89 =01V@ 4;O B5ABC Prolactin  /Prolactin  CalSet54337 - @>;0:B8= IVD (4V03=>AB8:0 in vitro ), :0;V1@0B>@;O 0=0;V70B>@0 cobas e 411 4 x 1 <; (ml) PRL Cal1: 2 D;0:>=8, ?> 1.0 <; :0;V1@0B>@0 1 PRL Cal2: 2 D;0:>=8, ?> 1.0 <; :0;V1@0B>@0 2 @>;0:B8= (;N4AL:89, @5:><1V=0=B=89, 7 E. coli) C 42>E 4V0?07>=0E :>=F5=B@0FV9 (?@81;87=> 2 <:/<; 01> 0.09 =3/<; B0 ?@81;87=> 2000 <:/<; 01> 94 =3/<;) C 1CD5@=V9 <0B@8FV :>=OG>W A8@>20B:8.=01V@230"5AB 4;O 287=0G5==O :>@B87>;C II54125 - 030;L=89 :>@B87>; IVD (4V03=>AB8:0 in vitro ), =01V@, E5<V;N<V=5AF5=B=89 V<C=>;>3VG=89 0=0;V;O 0=0;V70B>@0 cobas e 411 100 B5ABV2 (B0B82 4;O @50:B82V2 <0T <0@:C20==O CORT II. M V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=>< (?@>7>@0 :@8H:0), 1 D;0:>=, 6.5 <;: V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=><, 0.72 <3/<;; :>=A5@20=B. R1 =B8BV;0 4> :>@B87>;C~1V>B8= (AV@89 :>2?0G>:), 1 D;0:>=, 10 <;: V>B8=V;L>20=5 <>=>:;>=0;L=5 0=B8BV;> 4> :>@B87>;C (>25G5) 20 =3/<;; 40=07>; 20 <:3/<; MESb)-1CD5@ 100 <<>;L/;, pH 6.0, :>=A5@20=B. R2 >@B87>;-?5?B84~Ru(bpy) (G>@=89 :>2?0G>:), 1 D;0:>=, 10 <;: >EV4=5 :>@B87>;C (A8=B5B8G=5), <VG5=5 :><?;5:A>< @CB5=VN 20 =3/<;; 40=07>; 20 <:3/<;; !-1CD5@ 100 <<>;L/;, pH 6.0; :>=A5@20=B.HB5310;V1@C20;L=89 =01V@ 4;O B5ABC 4;O 287=0G5==O :>@B87>;C II54126 - 030;L=89 :>@B87>; IVD (4V03=>AB8:0 in vitro ), :0;V1@0B>@;O 0=0;V70B>@0 cobas e 411 4 x 1 <; (ml) CORT II Cal1: 2 D;0:>=8, ?> 1.0 <; :0;V1@0B>@0 1 CORT II Cal2: 2 D;0:>=8, ?> 1.0 <; :0;V1@0B>@0 2 >@B87>; (A8=B5B8G=89) C 42>E 4V0?07>=0E :>=F5=B@0FV9 (?@81;87=> 12.5 =<>;L/; 01> 0.45 <:3/4; V ?@81;87=> 1000 =<>;L/; 01> 36 <:3/4;) C <0B@8FV A8@>20B:8 :@>2V ;N48=8.=01V@23201V@ @5035=BV2 Elecsys 4;O :V;L:VA=>3> 287=0G5==O AC<8 E>@V>=VG=>3> 3>=04>B@>?V=C ;N48=8 (%) V 15B0-AC1>48=8FV (HCG+)54211 - 030;L=89 E>@V>=VG=89 3>=04>B@>?V= ;N48=8 (%) IVD (4V03=>AB8:0 in vitro ), =01V@, V<C=>E5<V;N<V=5AF5=B=89 0=0;V7;O 0=0;V70B>@0 cobas e 411 100 B5ABV2 (B0B82 4;O @50:B82V2 <0T <0@:C20==O HCG BETA. M V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=>< (?@>7>@89 :>2?0G>:), 1 D;0:>=, 6.5 <;: V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=><, 0.72 <3/<;; :>=A5@20=B. R2 =B8-%-0=B8BV;>~Ru(bpy) (G>@=89 :>2?0G>:), 1 D;0:>=, 10 <;: >=>:;>=0;L=5 0=B8 %-0=B8BV;> (<8H0G5), <VG5=5 :><?;5:A>< @CB5=VN 4.6 <3/;; D>AD0B=89 1CD5@ 40 <<>;L/;, pH 6.5; :>=A5@20=B R1 =B8-%-0=B8BV;>~1V>B8= (AV@89 :>2?0G>:), 1 D;0:>=, 9 <;: V>B8=V;L>20=V <>=>:;>=0;L=V 0=B8 % 0=B8BV;0 (<8H0GV) 2.6 <3/;; D>AD0B=89 1CD5@ 40 <<>;L/;, pH 7.5; :>=A5@20=B.HB12330;V1@C20;L=89 =01V@ 4;O :0;V1@C20==O :V;L:VA=>3> 287=0G5==O AC<8 E>@V>=VG=>3> 3>=04>B@>?V=C ;N48=8 (%) V 15B0-AC1>48=8FV (HCG+ )38266 - %>@V>=VG=89 3>=04>B@>?V= ;N48=8 15B0-AC1>48=8FO (15B0-%) IVD (4V03=>AB8:0 in vitro ), :0;V1@0B>@@;O 0=0;V70B>@0 cobas e 411 4 x 1 <; (ml) HCG+ Cal1: 2 D;0:>=8, ?> 1.0 <; :0;V1@0B>@0 1 2 :>6=><C HCG+ Cal2: 2 D;0:>=8, ?> 1.0 <; :0;V1@0B>@0 2 2 :>6=><C %>@V>=VG=89 3>=04>B@>?V= ;N48=8 (7 A5GV) C 42>E 4V0?07>=0E :>=F5=B@0FV9 (?@81;87=> 1.5 </<; B0 ?@81;87=> 2000 </<;) C 701CD5@5=><C <0B@8:AV A8@>20B:8 :@>2V ;N48=8.=01V@334"5AB 4;O :V;L:VA=>3> 287=0G5==O ?@>:0;LF8B>=V=C, 100 HB, 25@.258731 - @>:0;LF8B>=V= IVD (4V03=>AB8:0 in vitro ), =01V@, V<C=>E5<V;N<V=5AF5=B=89 0=0;V7 ;O 0=0;V70B>@0 cobas e 411 100 B5ABV2 (B0B82 4;O @50:B82V2 (M, R1, R2) <0T <0@:C20==O PCT. M V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=>< (?@>7>@89 :>2?0G>:), 1 D;0:>=, 6.5 <;: V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=><, 0.72 <3/<;; :>=A5@20=B R1 =B8BV;> 4> 0=B835=C "~1V>B8= (AV@89 :>2?0G>:), 1 D;0:>=, 9 <;: V>B8=V;L>20=5 <>=>:;>=0;L=5 0=B8BV;> 4> 0=B835=C " (<8H0G5) 2.0 <:3/<;; D>AD0B=89 1CD5@ 95 <<>;L/;, pH 7.5; :>=A5@20=B. R2 =B8BV;> 4> 0=B835=C "~Ru(bpy) (G>@=89 :>2?0G>:), 1 D;0:>=, 9 <;: >=>:;>=0;L=5 0=B8BV;> 4> 0=B835=C " (<8H0G5), <VG5=5 :><?;5:A>< @CB5=VN, 5.6 <:3/<;; D>AD0B=89 1CD5@ 95 <<>;L/;, pH 7.5; :>=A5@20=B. PCT Cal1 0;V1@0B>@ " 1 (1V;89 :>2?0G>:), 1 D;0:>= (;V>DV;V7>20=89) ?> 4 <;: " (@5:><1V=0=B=89) ?@81;87=> 0.10 =3/<; C <0B@8FV A8@>20B:8 :@>2V ;N48=8; :>=A5@20=B. PCT Cal2 0;V1@0B>@ " 2 (G>@=89 :>2?0G>:), 1 D;0:>= (;V>DV;V7>20=89) ?> 4 <;: " (@5:><1V=0=B=89) ?@81;87=> 54 =3/<; C <0B@8FV A8@>20B:8 :@>2V ;N48=8; :>=A5@20=B. PC PCT1 PreciControl PCT 1 (1565289 :>2?0G>:), 2 D;0:>=8 (;V>DV;V7>20=V) ?> 4 <;: " (@5:><1V=0=B=89) ?@81;87=> 0.50 =3/<; C <0B@8FV A8@>20B:8 :@>2V ;N48=8; :>=A5@20=B. PC PCT2 PreciControl PCT 2 (:>@8G=5289 :>2?0G>:), 2 D;0:>=8 (;V>DV;V7>20=V) ?> 4 <;: " (@5:><1V=0=B=89) ?@81;87=> 10 =3/<; C <0B@8FV A8@>20B:8 :@>2V ;N48=8; :>=A5@20=B.=01V@53501V@ @5035=BV2 Elecsys 4;O 287=0G5==O IgG 0=B8BV; 4> 2V@CAC :@0A=CE8 (Rubella IgG)60990 - V@CA :@0A=CE8, 0=B8BV;0 :;0AC V<C=>3;>1C;V= G (IgG) IVD (4V03=>AB8:0 in vitro ), =01V@, V<C=>E5<V;N<V=5AF5=B=89 0=0;V7;O 0=0;V70B>@0 cobas e 411 100 B5ABV2 (B0B82 4;O @50:B82V2 (M, R1, R2) <0T <0@:C20==O RUBIGG. M V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=>< (?@>7>@89 :>2?0G>:), 1 D;0:>=, 6.5 <;: V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=><, 0.72 <3/<;; :>=A5@20=B. R1 =B8-h IgG-Ab~1V>B8= (AV@89 :>2?0G>:), 1 D;0:>=, 10 <;: V>B8=V;L>20=5 <>=>:;>=0;L=5 0=B8-h IgG 0=B8BV;> (<8H0G5), 2V@CA>?>4V1=V G0AB8=:8 :@0A=CE8 (RLP), D>AD0B=89 1CD5@, pH 6.8; :>=A5@20=B. R2 =B8-Rubella-Ab-D@03<5=B~Ru(bpy) , @5:><1V=0=B=89 E1~1V>B8=, @5:><1V=0=B=89 E1~Ru (bpy) (G>@=0 :@8H:0), 1 D;0:>=, 10 <;: CB5=V;L>20=89 <>=>:;>=0;L=89 D@03<5=B 0=B8BV; 4> 2V@CAC Rubella, 1V>BV=V;L>20=89 @5:><1V=0=B 1, @CB5=V;L>20=89 @5:><1V=0=B 1, D>AD0B=89 1CD5@, pH 6.8; :>=A5@20=B. RUBIGG Cal1 530B82=89 :0;V1@0B>@ 1 (1V;0 :@8H:0), 2 D;0:>=8 ?> 1.0 <; :>65=: !8@>20B:0 :@>2V ;N48=8, =5@50:B82=0 I>4> 0=B8BV; IgG 4> 2V@CAC Rubella; :>=A5@20=B. RUBIGG Cal2 >78B82=89 :0;V1@0B>@ 2 (G>@=0 :@8H:0), 2 D;0:>=8 ?> 1.0 <; :>65=: =B8-Rubella IgG ?@81;87=> 400 /<; C A8@>20BFV :@>2V ;N48=8; :>=A5@20=B.HB113601V@ :>=B@>;L=8E A8@>20B>: PreciControl 4;O 287=0G5==O 0=B8BV; :;0AC IgG 4> 2V@CAC :@0A=CE8 (Rubella IgG)42140 - V@CA :@0A=CE8, 0=B8BV;0 :;0AC V<C=>3;>1C;V= G (IgG), :>=B@>;L=89 <0B5@V0;, IVD (4V03=>AB8:0 in vitro );O 0=0;V70B>@0 cobas e 411 16 E 1 <; (ml) PC RUBIGG1: 8 D;0:>=V2, ?> 1.0 <; :>=B@>;L=>W A8@>20B:8 !8@>20B:0 :@>2V ;N48=8, =530B82=0 01> =87L:> ?>78B82=0 =0 0=B8BV;0 :;0AC IgG 4> 2V@CAC :@0A=CE8 (1;87L:> 4 /<;); :>=A5@20=B. PC RUBIGG2: 8 D;0:>=V2, ?> 1.0 <; :>=B@>;L=>W A8@>20B:8 !8@>20B:0 :@>2V ;N48=8, ?>78B82=0 =0 0=B8BV;0 :;0AC IgG 4> 2V@CAC :@0A=CE8 (1;87L:> 75 /<;); :>=A5@20=B.=01V@23701V@ @5035=BV2 Elecsys 4;O 287=0G5==O 0=B8BV; :;0AC IgM 4> 2V@CAC :@0A=CE8 (Rubella IgM)60991 - V@CA :@0A=CE8, 0=B8BV;0 :;0AC V<C=>3;>1C;V= M (IgM) IVD (4V03=>AB8:0 in vitro ), =01V@, V<C=>E5<V;N<V=5AF5=B=89 0=0;V7;O 0=0;V70B>@0 cobas e 411 100 B5ABV2 (B0B82 4;O @50:B82V2 (M, R1, R2) <0T <0@:C20==O RUBIGM. M V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=>< (?@>7>@0 :@8H:0), 1 D;0:>=, 6.5 <;: V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=><, 0.72 <3/<;; :>=A5@20=B. R1 =B8BV;0 4> h-IgM~1V>B8=; A?5F8DVG=V 4> 2V@CAC :@0A=CE8 @5:><1V=0=B=V 0=B835=8 (AV@0 :@8H:0), 1 D;0:>=, 10 <;: V>B8=V;L>20=V <>=>:;>=0;L=V 0=B8BV;0 4> h-IgM (<8H0GV) > 500 =3/<;, G0AB8=:8, ?>4V1=V 4> 2V@CAC :@0A=CE8 (RLP), ?@81;87=> 0.1 4/<;; =0B@VT2>-D>AD0B=89 1CD5@ pH 7.7; :>=A5@20=B. R2 =B8BV;0 4> 2V@CAC :@0A=CE8~Ru(bpy) (G>@=0 :@8H:0), 1 D;0:>=, 10 <;: =B8BV;0 4> 2V@CAC :@0A=CE8, <VG5=V :><?;5:A>< @CB5=VN > 400 =3/<;; =0B@VT2>-D>AD0B=89 1CD5@ pH 7.7; :>=A5@20=B. RUBIGM Cal1 530B82=89 :0;V1@0B>@ 1 (1V;0 :@8H:0), 2 D;0:>=8 ?> 1.0 <; :>65=: !8@>20B:0 :@>2V ;N48=8, =5@50:B82=0 =0 0=B8BV;0 IgM 4> 2V@CAC :@0A=CE8; :>=A5@20=B. RUBIGM Cal2 >78B82=89 :0;V1@0B>@ 2 (G>@=0 :@8H:0), 2 D;0:>=8 ?> 1.0 <; :>65=: =B8BV;0 IgM 4> 2V@CAC :@0A=CE8 ?@81;87=> 700 4/<; (>48=8FL Roche) C 1CD5@V; :>=A5@20=B.HB103801V@ :>=B@>;L=8E A8@>20B>: PreciControl 4;O 287=0G5==O 0=B8BV; :;0AC IgM 4> 2V@CAC :@0A=CE8 (Rubella IgM)42142 - V@CA :@0A=CE8, 0=B8BV;0 :;0AC V<C=>3;>1C;V=  (Ig), :>=B@>;L=89 <0B5@V0;, IVD (4V03=>AB8:0 in vitro );O 0=0;V70B>@0 cobas e 411 8 E 1 <; (ml) PC RUBIGM1: 4 D;0:>=8, ?> 1.0 <; :>=B@>;L=>W A8@>20B:8 !8@>20B:0 :@>2V ;N48=8, =530B82=0 =0 0=B8BV;0 IgM 4> 2V@CAC :@0A=CE8; :>=A5@20=B. PC RUBIGM2: 4 D;0:>=8, ?> 1.0 <; :>=B@>;L=>W A8@>20B:8 !8@>20B:0 :@>2V ;N48=8, ?>78B82=0 =0 0=B8BV;0 IgM 4> 2V@CAC :@0A=CE8, ?@81;87=> 550 4/<; (4>2V;L=> 2V4V1@0=0 >48=8FO Roche); :>=A5@20=B.=01V@23901V@ @5035=BV2 Elecsys 4;O 287=0G5==O 0=B8BV; :;0AC Ig 4> B>:A>?;07<8 (Toxo IgM)52442 - ">:A>?;07<0, 0=B8BV;0 :;0AC V<C=>3;>1C;V= M (IgM) IVD (4V03=>AB8:0 in vitro ), =01V@, V<C=>E5<V;N<V=5AF5=B=89 0=0;V7;O 0=0;V70B>@0 cobas e 411 100 B5ABV2 (B0B82 4;O @50:B82V2 (M, R1, R2) <0T <0@:C20==O TOXIGM. M V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=>< (?@>7>@0 :@8H:0), 1 D;0:>=, 6.5 <;: V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=><, 0.72 <3/<;; :>=A5@20=B. R1 =B835= B>:A>?;07<8~Ru(bpy) (AV@0 :@8H:0), 1 D;0:>=, 9 <;: =B835= B>:A>?;07<8, <VG5=89 :><?;5:A>< @CB5=VN > 1 <3/;; 1CD5@ MESb) 50 <<>;L/;, pH 6.0; :>=A5@20=B. R2 =B8BV;0 4> 0=B835=C h IgM~1V>B8= (G>@=0 :@8H:0), 1 D;0:>=, 9 <;: V>B8=V;L>20=V <>=>:;>=0;L=V 0=B8BV;0 (<8H0GV) 4> IgM ;N48=8 > 500 <:3/;; 1CD5@ HEPESc) 50 <<>;L/;, pH 7.2; :>=A5@20=B. b) MES = 2 <>@D>;V=> 5B0=AC;LD>=>20 :8A;>B0 c) HEPES = [4 (2 3V4@>:A85B8;) ?V?5@078=] 5B0=AC;LD>=>20 :8A;>B0 TOXIGM Cal1 530B82=89 :0;V1@0B>@ 1 (1V;0 :@8H:0), 2 D;0:>=8 ?> 0.67 <;: !8@>20B:0 :@>2V ;N48=8, =530B82=0 =0 0=B8BV;0 IgM 4> B>:A>?;07<8; :>=A5@20=B. TOXIGM Cal2 >78B82=89 :0;V1@0B>@ 2 (G>@=0 :@8H:0), 2 D;0:>=8 ?> 0.67 <;: =B8BV;0 IgM 4> B>:A>?;07<8 (;N48=8) ?@81;87=> 130 4/<; (>48=8FV Roche) C A8@>20BFV :@>2V ;N48=8; :>=A5@20=B.=01V@104001V@ :>=B@>;L=8E A8@>20B>: PreciControl 4;O 287=0G5==O 0=B8BV; :;0AC Ig 4> B>:A>?;07<8 (Toxo IgM)42164 - Toxoplasma gondii, 0=B8BV;0 :;0AC V<C=>3;>1C;V=C M (IgM), :>=B@>;L=89 <0B5@V0;, IVD (4V03=>AB8:0 in vitro);O 0=0;V70B>@0 cobas e 411 16 E 0,67 <; (ml) PC TOXIGM1: 8 D;0:>=V2, ?> 0.67 <; :>=B@>;L=>W A8@>20B:8 !8@>20B:0 :@>2V ;N48=8, =530B82=0 =0 0=B8BV;0 IgM 4> B>:A>?;07<8; :>=A5@20=B. PC TOXIGM2: 8 D;0:>=V2, ?> 0.67 <; :>=B@>;L=>W A8@>20B:8 !8@>20B:0 :@>2V ;N48=8, ?>78B82=0 =0 0=B8BV;0 IgM 4> B>:A>?;07<8, ?@81;87=> 125 /<; (4>2V;L=> 2V4V1@0=0 >48=8FO Roche); :>=A5@20=B.=01V@24101V@ @5035=BV2 Elecsys 4;O 287=0G5==O 0=B8BV; :;0AC IgG 4> B>:A>?;07<8 (Toxo IgG)52438 - ">:A>?;07<0, 0=B8BV;0 :;0AC V<C=>3;>1C;V= G (IgG) IVD (4V03=>AB8:0 in vitro ), =01V@, V<C=>E5<V;N<V=5AF5=B=89 0=0;V7;O 0=0;V70B>@0 cobas e 411 100 B5ABV2 (B0B82 4;O @50:B82V2 (M, R1, R2) <0T <0@:C20==O TOXIGG. M V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=>< (?@>7>@89 :>2?0G>:), 1 D;0:>=, 6.5 <;: V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=><, 0.72 <3/<;; :>=A5@20=B. R1 =B835= B>:A>?;07<8~1V>B8= (AV@89 :>2?0G>:), 1 D;0:>=, 9 <;: V>B8=V;L>20=89 T. gondii A?5F8DVG=89 0=B835= (@5:><1V=0=B=89, E. coli), > 400 <:3/;, TRIS 1CD5@ 50 <<>;L/;, pH 7.5; :>=A5@20=B. R2 =B835= B>:A>?;07<8~Ru(bpy) (G>@=89 :>2?0G>:), 1 D;0:>=, 9 <;: T. gondii A?5F8DVG=89 0=B835= (@5:><1V=0=B=89, E. Aoli) <VG5=89 :><?;5:A>< @CB5=VN > 400 <:3/;, TRIS 1CD5@ 50 <<>;L/;, pH 7.5; :>=A5@20=B. TOXIGG Cal1 530B82=89 :0;V1@0B>@ 1 (1V;89 :>2?0G>:), 2 D;0:>=8 ?> 1.0 <; :>65=: !8@>20B:0 :@>2V ;N48=8, =5@50:FV9=0 =0 0=B8BV;0 IgG 4> B>:A>?;07<8; 1CD5@; :>=A5@20=B. TOXIGG Cal2 >78B82=89 :0;V1@0B>@ 2 (G>@=89 :>2?0G>:), 2 D;0:>=8 ?> 1.0 <; :>65=: !8@>20B:0 :@>2V ;N48=8, @50:FV9=0 =0 0=B8BV;0 IgG 4> B>:A>?;07<8; ?@81;87=> 100 /<;; 1CD5@; :>=A5@20=B.=01V@114201V@ :>=B@>;L=8E A8@>20B>: PreciControl 4;O 287=0G5==O 0=B8BV; :;0AC IgG 4> B>:A>?;07<8 (Toxo IgG)42167 - Toxoplasma gondii, 0=B8BV;0 :;0AC V<C=>3;>1C;V=C G (IgG), :>=B@>;L=89 <0B5@V0;, IVD (4V03=>AB8:0 in vitro );O 0=0;V70B>@0 cobas e 411 16 E 1 <; (ml) PC TOXIGG1: 8 D;0:>=V2, ?> 1.0 <; :>=B@>;L=>W A8@>20B:8 2 :>6=><C !8@>20B:0 :@>2V ;N48=8, =530B82=0 01> A;01> ?>78B82=0 =0 0=B8BV;0 IgG 4> B>:A>?;07<8 (?@81;87=> 1 /<;); :>=A5@20=B. PC TOXIGG2: 8 D;0:>=V2, ?> 1.0 <; :>=B@>;L=>W A8@>20B:8 2 :>6=><C !8@>20B:0 :@>2V ;N48=8, ?>78B82=0 =0 0=B8BV;0 IgG 4> B>:A>?;07<8 (?@81;87=> 50 /<;); :>=A5@20=B.=01V@243<C=>0=0;V7 4;O O:VA=>3> 287=0G5==O 0=B8BV; :;0AC IgG 4> -1; cobas e 411, e 601, e 60249543 - V@CA ?@>AB>3> 35@?5AC 1 V 2 (HSV1 V 2), V<C=>3;>1C;V= G (IgG), 0=B8BV;0 IVD (4V03=>AB8:0 in vitro ), =01V@, E5<V;N<V=5AF5=B=89 0=0;V;O 0=0;V70B>@0 cobas e 411 100 B5ABV2 (B0B82 4;O @50:B82V2 (M, R1, R2) <0T <0@:C20==O HSV 1. M V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=>< (?@>7>@89 :>2?0G>:), 1 D;0:>=, 6.5 <;: V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=><, 0.72 <3/<;; :>=A5@20=B. R1 =B835=8 -1~1V>B8= (AV@89 :>2?0G>:), 1 D;0:>=, 9 <;: V>B8=V;L>20=89 A?5F8DVG=89 0=B835= -1 (@5:><1V=0=B=89, E. coli) > 150 <:3/;; 1CD5@ !b) 50 <<>;L/;, pH 6.5; :>=A5@20=B. R2 =B835=8 -1~Ru(bpy) (G>@=89 :>2?0G>:), 1 D;0:>=, 9 <;: !?5F8DVG=89 0=B835= -1 (@5:><1V=0=B=89, E. Aoli), <VG5=89 :><?;5:A>< @CB5=VN, > 150 <:3/;, 1CD5@ ! 50 <<>;L/;, pH 6.5; :>=A5@20=B. b) ME! = 2<>@D>;V=>5B0=AC;LD>=>20 :8A;>B0 LNPn|  " $ ϳv`J:hEhE5CJaJmH"sH"+hEhE5B*CJ\aJmH"phsH"+hEh5B*CJ\aJmH"phsH"%h5B*CJ\aJmH"phsH"h5CJOJQJaJhuU5CJOJQJaJhbh5CJOJQJaJ6hbhB*CJOJQJaJfHphq hbhCJOJQJ\aJ"hbh56mH"nH"sH"tH"h56mH"nH"sH"tH"LNP ooK$$ "( Px 4 #\'*.25@9-D1$M a$gd! "( Px 4 #\'*.25@9-D1$M gd5$$d%d&d'd(d*$1$NOPQRa$gd:$d%d&d'd(d*$1$NOPQR^`gd    : b "$ A1$7$8$H$`a$gduUm$ $7$8$a$gdW$*$-D1$7$8$H$M a$gdW$a$gdLI$a$gdW$-D9DM a$gd $*$1$a$gdE    : N tgg[MAhhW\mH"sH"hhW6PJmH"sH"hhW6mH"sH"hLIhWPJmH"sH"h?/MhLI5PJmH"sH"hLIhLIPJmH"sH"hLIPJmH"sH"hhWmH"nH"sH"tH"hhWPJmH"sH"hhWmH"sH"hhW5PJ\mH"sH"hW5PJ\mH"sH"hECJOJQJaJmH"sH"$hEhECJOJQJaJmH"sH"`bd$b "Zjrv  "L"ȳȫȁvvkkkkv[NhuU56PJmH"sH"huUhuU56PJmH"sH"huU56mH"sH"hW56mH"sH"hhW56mH"sH" h/3h?/MPJmH"nH sH"tH h/3h?/MmH"sH"hWmH"sH"hhWPJmH"sH"hmH"sH"hhWmH"sH"hLImH"sH"h?/MhLI5PJmH"sH"hLIhLIPJmH"sH"hP!PJmH"sH" """""8&D&P&b&z&&&&& $$Ifa$gd@R $$*$Ifa$gd@R$ A1$7$8$`a$gdW%$ "( Px 4 #\'*.25@9*$-D1$M a$gd$dd^a$gdW$ & F 1$7$8$H$a$gduUm$L"`"""""""#&#.#2#V$$$%%%||l_lO@hBrhWmH"nHsH"tHhBrhW56PJmH"sH"hp756PJmH"sH"hhW56PJmH"sH"hW56mH"sH"hhW56mH"sH"+h{h}#CJOJQJ\^JaJnH"tH"(hhW5fHmH"q sH"hhW5PJmH"sH"h5PJmH"sH"huUhuU56mH"sH"huU56mH"sH"hhuU56mH"sH"%&&"&$&2&4&6&8&P&`&b&h&x&z&&&&δvdXP;v-hA"*CJOJQJ^JaJ(hHhHCJOJQJ^JaJmH"sH"hHCJaJhHCJaJmH"sH""hA"*56CJ\]aJmH"sH"hA"*56CJ\]aJ$hEhA"*CJaJmHnHsHtHhsw?h~p.56PJmH"sH"hUC56PJmH"sH"hP!56PJmH"sH"hp756PJmH"sH"hhW56PJmH"sH"hBrhW56PJmH"sH""hBrhW56mH"nHsH"tH&&&&''' '''''''(--- -"-&-l-Ff$If $$Ifa$Ff $$Ifa$gdp7 $$*$Ifa$gdp7Ff $$*$Ifa$gd@R&&&&' '''''''((------ -"-ʶsk\G8GsshehA"*CJaJmHsH(hehA"*CJOJQJ^JaJmHsHhehA"*CJaJmHsHhA"*CJaJ$hEhA"*CJaJmHnHsHtHhA"*CJaJ$hEhp7CJaJmHnHsHtH(hp7hp756CJ$\]aJ$mH"sH"'hp7hp75CJ$aJ$mH"nHsH"tH$hEhA"*CJaJmHnHsHtH$hA"*hsw?CJaJmH"nHsH"tHhA"*CJaJmH"nHsH"tH"-$-&-j-l-..d0f0p0r0t0v0x0z0|0~00011b6d6h6j6l6n6p6r6t6v67777B:D:N:P:R:T:V:X:Z:\:::;;b@d@h@j@l@n@p@r@ݼʥݼʥ(hehA"*CJOJQJ^JaJmHsHhehA"*CJaJmHsHhA"*CJaJhA"*CJOJQJ^JaJ$hEhA"*CJaJmHnHsHtHhA"*CJaJ$hEhA"*CJaJmHnHsHtHhA"*CJaJ8l-.f0r0v0x0z0~001d6j6n6p6r6v677D:P:T:V:X:\::FfFf FfM $$*$Ifa$gd@R$If $$Ifa$:;d@j@n@p@r@v@@^ACCCCCCrDDE6JJ@JBJDJFJHJJJ\K^KxMzMMMMMMMMMNNNN.P0Pʻʻ݁ʻhA"*CJOJQJ^JaJhA"*CJaJhehA"*CJaJmHsH(hehA"*CJOJQJ^JaJmHsHhehA"*CJaJmHsH$hEhA"*CJaJmHnHsHtHhA"*CJaJ$hEhA"*CJaJmHnHsHtHhA"*CJaJ2J^KzMMMMMMNN0PP@PBPDPHPJPPPQQUUUUUUUUUU V"VVV6Y8YBYDYFYHYJYLYPYRYYYZZB[^^^^^^^^^һʉһhA"*CJaJhA"*CJOJQJ^JaJhehA"*CJaJmHsH(hehA"*CJOJQJ^JaJmHsHhehA"*CJaJmHsHhA"*CJaJ$hEhA"*CJaJmHnHsHtH$hEhA"*CJaJmHnHsHtHhA"*CJaJ2"VV8YDYHYJYLYRYYZ^^^^^^x__hbtbxbzb|bbbFfe.Ff+Ff' $$*$Ifa$gd@R$If $$Ifa$^^v_x___fbhbrbtbvbxbzb|bbbbbccXhZh^h`hbhdhfhhhlhnhhh2i4ikkkkkkkkkk\l˼ː˼rː˼ːhA"*CJOJQJ^JaJhA"*CJaJhA"*CJaJhA"*CJaJhehA"*CJaJmHsH(hehA"*CJOJQJ^JaJmHsHhehA"*CJaJmHsH$hEhA"*CJaJmHnHsHtHhIhA"*CJaJmHsH$hEhA"*CJaJmHnHsHtH,bcZh`hdhfhhhnhh4ikkkkkk^lrmqqqqqq$rFf=8Ff4Ff1 $$*$Ifa$gd@R$If $$Ifa$\l^lpmrmqqqqqqqqqq"r$rs sBuDuNuPuRuTuVuXu\u^uvvvv{{{{{{{{{{|||ɁɫrrhIhA"*CJaJmHsHhehA"*CJaJmHsHhA"*CJaJ$hEhA"*CJaJmHnHsHtHhA"*CJaJhA"*CJOJQJ^JaJhA"*CJaJ(hehA"*CJOJQJ^JaJmHsHhehA"*CJaJmHsH$hEhA"*CJaJmHnHsHtH,$r sDuPuTuVuXu^uvv{{{{{{||~~~~~~@FfBFf>Ff; $$*$Ifa$gd@R$If $$Ifa$||~~~~~~~~~~>@HJ؅څ LNԮ돁Ԯr돁ԮhIhA"*CJaJmHsHhA"*CJOJQJ^JaJhA"*CJaJhehA"*CJaJmHsHhA"*CJaJ$hEhA"*CJaJmHnHsHtH$hEhA"*CJaJmHnHsHtHhA"*CJaJhehA"*CJaJmHsH(hehA"*CJOJQJ^JaJmHsH,@Jڅ NflprtzFfKFfHFf]E $$*$Ifa$gd@R$If $$Ifa$dfjlnprtxzdfPRԘ֘ژܘޘϴϴrhehA"*CJaJmHsH(hehA"*CJOJQJ^JaJmHsHhehA"*CJaJmHsHhIhA"*CJaJmH sH hA"*CJaJ$hEhA"*CJaJmHnHsHtH$hEhA"*CJaJmHnHsHtHhA"*CJaJhA"*CJOJQJ^JaJhA"*CJaJ*fR֘ܘRܙFfUFf}RFf5O $$*$Ifa$gd@R$If $$Ifa$PRڙܙ ȸ޸ޖr޸ޖr޸hehA"*CJaJmHsH(hehA"*CJOJQJ^JaJmHsHhehA"*CJaJmHsH$hEhA"*CJaJmHnHsHtHhA"*CJaJhA"*CJaJhA"*CJOJQJ^JaJhA"*CJaJ$hEhA"*CJaJmHnHsHtHhIhA"*CJaJmHsH, 2NTXZ\bFf_FfU\Ff Y $$*$Ifa$gd@R$If $$Ifa$02ܧLNRTVXZ\`bVX@B ڵܵdfŷzܯrŷrhA"*CJaJhIhA"*CJaJmHsH$hEhA"*CJaJmHnHsHtH$hEhA"*CJaJmHnHsHtHhA"*CJaJhA"*CJOJQJ^JaJhA"*CJaJhehA"*CJaJmHsH(hehA"*CJOJQJ^JaJmHsHhehA"*CJaJmHsH,XBܵfXdhjlrfFfuiFf-fFfb $$*$Ifa$gd@R$If $$Ifa$fVXbdfhjlprdfZ\  RTڴǥrڴǥrrrڴhehA"*CJaJmHsH(hehA"*CJOJQJ^JaJmHsHhehA"*CJaJmHsHhIhA"*CJaJmHsH$hEhA"*CJaJmHnHsHtH$hEhA"*CJaJmHnHsHtHhA"*CJaJhA"*CJaJhA"*CJOJQJ^JaJhA"*CJaJ,f\ FfMsFfpFfl $$*$Ifa$gd@R$If $$Ifa$îҁrîҁrîҁhIhA"*CJaJmHsHhA"*CJaJhA"*CJOJQJ^JaJhA"*CJaJhehA"*CJaJmHsH(hehA"*CJOJQJ^JaJmHsHhehA"*CJaJmHsH$hEhA"*CJaJmHnHsHtHhA"*CJaJ$hEhA"*CJaJmHnHsHtH,Ff%}FfyFfv $$*$Ifa$gd@R$If $$Ifa$Jxzdfprtvxz~$& .0:<@BDFJL˼zzzz˼zzzz˼zzzzhA"*CJaJhA"*CJOJQJ^JaJhA"*CJaJhehA"*CJaJmHsH(hehA"*CJOJQJ^JaJmHsHhehA"*CJaJmHsH$hEhA"*CJaJmHnHsHtHhS OhA"*CJaJmHsH$hEhA"*CJaJmHnHsHtH-zfrvxz& 0<BDFLFfFfFfm $$*$Ifa$gd@R$If $$Ifa$L`Z\fhlnprvx>@&(: < F H J L N P T V  壐r壐壐hehA"*CJaJmHsHhS OhA"*CJaJmHsH$hEhA"*CJaJmHnHsHtHhA"*CJaJhA"*CJOJQJ^JaJhA"*CJaJ(hehA"*CJOJQJ^JaJmHsHhehA"*CJaJmHsH$hEhA"*CJaJmHnHsHtHhA"*CJaJ,\hnprx@(< H L N P V  & j`v`|`~```:aFfՐFfFfE $$*$Ifa$gd@R$If $$Ifa$  $ &  L^h`j`t`v`z`|`~````8a:aTbVbciiiiiiiijjXjZjtkvkpppp p"p$p&p*pɺ횇xɺ횇pɲhA"*CJaJhS OhA"*CJaJmHsH$hEhA"*CJaJmHnHsHtHhA"*CJaJhA"*CJOJQJ^JaJUhA"*CJaJhehA"*CJaJmHsH(hehA"*CJOJQJ^JaJmHsHhehA"*CJaJmHsH$hEhA"*CJaJmHnHsHtH,HSV 1 Cal1 530B82=89 :0;V1@0B>@ 1 (1V;89 :>2?0G>:), 2 D;0:>=8 (;V>DV;V7>20=V) ?> 1.0 <;: !8@>20B:0 :@>2V ;N48=8, =5@50:FV9=0 =0 IgG 4>  1; :>=A5@20=B. HSV 1 Cal2 >78B82=89 :0;V1@0B>@ 2 (G>@=89 :>2?0G>:), 2 D;0:>=8 (;V>DV;V7>20=V) ?> 1.0 <;: !8@>20B:0 :@>2V ;N48=8, @50:FV9=0 =0 IgG 4>  1; :>=A5@20=B.=01V@1044<C=>0=0;V7 4;O O:VA=>3> 287=0G5==O 0=B8BV; :;0AC IgG 4> -2; cobas e 411, e 601, e 60249543 - V@CA ?@>AB>3> 35@?5AC 1 V 2 (HSV1 V 2), V<C=>3;>1C;V= G (IgG), 0=B8BV;0 IVD (4V03=>AB8:0 in vitro ), =01V@, E5<V;N<V=5AF5=B=89 0=0;V;O 0=0;V70B>@0 cobas e 411 100 B5ABV2 (B0B82 4;O @50:B82V2 (M, R1, R2) <0T <0@:C20==O HSV 2. M V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=>< (?@>7>@89 :>2?0G>:), 1 D;0:>=, 6.5 <;: V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=><, 0.72 <3/<;; :>=A5@20=B. R1 =B835=8 -2~1V>B8= (AV@89 :>2?0G>:), 1 D;0:>=, 9 <;: V>B8=V;L>20=89 A?5F8DVG=89 0=B835= -2 (@5:><1V=0=B=89, E. coli) > 150 <:3/;; 1CD5@ !b) 50 <<>;L/;, pH 6.5; :>=A5@20=B. R2 =B835=8 -2~Ru(bpy) (G>@=89 :>2?0G>:), 1 D;0:>=, 9 <;: !?5F8DVG=89 0=B835= -2 (@5:><1V=0=B=89, E. Aoli), <VG5=89 :><?;5:A>< @CB5=VN, > 150 <:3/;, 1CD5@ ! 50 <<>;L/;, pH 6.5; :>=A5@20=B. b) ME! = 2-<>@D>;V=>5B0=AC;LD>=>20 :8A;>B0 HSV 2 Cal1 530B82=89 :0;V1@0B>@ 1 (1V;89 :>2?0G>:), 2 D;0:>=8 (;V>DV;V7>20=V) ?> 1.0 <;: !8@>20B:0 :@>2V ;N48=8, =5@50:FV9=0 =0 IgG 4>  2; :>=A5@20=B. HSV 2 Cal2 >78B82=89 :0;V1@0B>@ 2 (G>@=89 :>2?0G>:), 2 D;0:>=8 (;V>DV;V7>20=V) ?> 1.0 <;: !8@>20B:0 :@>2V ;N48=8, @50:FV9=0 =0 IgG 4>  2; :>=A5@20=B.=01V@114501V@ :>=B@>;L=8E A8@>20B>: 4;O B5ABV2 HSV52792 - V@CA ?@>AB>3> 35@?5AC B8?C 1 B0 2 (HSV1 & 2), 0=B8BV;0 :;0AC V<C=>3;>1C;V= G (IgG) IVD (4V03=>AB8:0 in vitro ), :>=B@>;L=89 <0B5@V0;;O 0=0;V70B>@0 cobas e 411 4 E 3 <; (ml) PC HSV1: 2 D;0:>=8, ?> 3.0 <; :>=B@>;L=>W A8@>20B:8 !8@>20B:0 :@>2V ;N48=8, =530B82=0 =0 0=B8BV;0 IgG 4>  1 B0 0=B8BV;0 IgG 4>  2; :>=A5@20=B. &V;L>25 7=0G5==O 4;O 3@0=8G=>3> V=45:AC: 0=B8BV;0 IgG 4>  1: ?@81;87=> 0.30  0=B8BV;0 IgG 4>  2: ?@81;87=> 0.30  % PC HSV2: 2 D;0:>=8, ?> 3.0 <; :>=B@>;L=>W A8@>20B:8 !8@>20B:0 :@>2V ;N48=8, ?>78B82=0 =0 0=B8BV;0 IgG 4>  1 B0 0=B8BV;0 IgG 4>  2; :>=A5@20=B. &V;L>25 7=0G5==O 4;O 3@0=8G=>3> V=45:AC: 0=B8BV;0 IgG 4>  1: ?@81;87=> 4.00  0=B8BV;0 IgG 4>  2: ?@81;87=> 8.00 =01V@24601V@ @5035=BV2 Elecsys 4;O O:VA=>3> 287=0G5==O 0=B8BV; :;0AC IgM 4> F8B><530;>2V@CAC (CMV IgM)49724 - Cytomegalovirus (CMV), V<C=>3;>1C;V= M (IgM), 0=B8BV;0 IVD (4V03=>AB8:0 in vitro ), =01V@, V<C=>E5<V;N<V=5AF5=B=89 0=0;V7;O 0=0;V70B>@0 cobas e 411 100 B5ABV2 (B0B82 4;O @50:B82V2 (M, R1, R2) <0T <0@:C20==O CMVIGM. M V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=>< (?@>7>@0 :@8H:0), 1 D;0:>=, 6.5 <;: V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=><, 0.72 <3/<;; :>=A5@20=B. CMVIGM Cal2 >78B82=89 :0;V1@0B>@ 2 (G>@=0 :@8H:0), 2 D;0:>=8 ?> 1.0 <; :>65=: =B8BV;0 IgM 4> & (A8@>20B:0 :@>2V ;N48=8) 2 1CD5@=><C @>7G8=V HEPES, pH 7.4; 18G0G89 0;L1C<V=; :>=A5@20=B. R1 =B8BV;0 4> h-IgM~1V>B8= (AV@0 :@8H:0), 1 D;0:>=, 9 <;: V>B8=V;L>20=V <>=>:;>=0;L=V 0=B8BV;0 4> h IgM (<8H0GV) > 500 <:3/;, 1CD5@ MES 50 <<>;L/;, pH 6.5; :>=A5@20=B. R2 =B835=8 &~Ru(bpy) (G>@=0 :@8H:0), 1 D;0:>=, 9 <;: & A?5F8DVG=V 0=B835=8 (@5:><1V=0=B=V, E. Aoli), <VG5=V :><?;5:A>< @CB5=VN, > 50 <:3/;, 1CD5@ MES 50 <<>;L/;, pH 5.5; :>=A5@20=B. CMVIGM Cal1 530B82=89 :0;V1@0B>@ 1 (1V;0 :@8H:0), 2 D;0:>=8 ?> 1.0 <; :>65=: !8@>20B:0 :@>2V ;N48=8, =530B82=0 =0 0=B8BV;0 IgM 4> &; :>=A5@20=B.=01V@104701V@ :>=B@>;L=8E A8@>20B>: PreciControl 4;O 287=0G5==O 0=B8BV; :;0AC IgM 4> F8B><530;>2V@CAC (CMV IgM)38294 - &8B><530;>2V@CA (CMV) 0=B8BV;0 :;0AC V<C=>3;>1C;V=C  (Ig) IVD (4V03=>AB8:0 in vitro ), :>=B@>;L=89 <0B5@V0;;O 0=0;V70B>@0 cobas e 411 16 E 1 <; (ml) PC CMVIGM1: 8 D;0:>=V2, ?> 1.0 <; :>=B@>;L=>W A8@>20B:8 2 :>6=><C !8@>20B:0 :@>2V ;N48=8, =530B82=0 =0 0=B8BV;0 IgM 4> &; :>=A5@20=B. PC CMVIGM2: 8 D;0:>=V2, ?> 1.0 <; :>=B@>;L=>W A8@>20B:8 2 :>6=><C !8@>20B:0 :@>2V ;N48=8, ?>78B82=0 =0 0=B8BV;0 IgM 4> &; 1CD5@ HEPES, pH 7.4; 18G0G89 0;L1C<V=; :>=A5@20=B=01V@24801V@ @5035=BV2 Elecsys 4;O 287=0G5==O 0=B8BV; :;0AC IgG 4> F8B><530;>2V@CAC (CMV IgG)49713 - Cytomegalovirus (CMV), V<C=>3;>1C;V= G (IgG), 0=B8BV;0 IVD (4V03=>AB8:0 in vitro ), =01V@, V<C=>E5<V;N<V=5AF5=B=89 0=0;V7;O 0=0;V70B>@0 cobas e 411 100 B5ABV2 (B0B82 4;O @50:B82V2 (M, R1, R2) <0T <0@:C20==O CMVIGG. M V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=>< (?@>7>@0 :@8H:0), 1 D;0:>=, 6.5 <;: <V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=>< 0.72 <3/<;; :>=A5@20=B. R1 & Ag~1V>B8= (AV@0 :@8H:0), 1 D;0:>=, 9 <;: V>B8=V;L>20=89 &-A?5F8DVG=89 0=B835= (@5:><1V=0=B=89, E. coli), > 400 <:3/;, 1CD5@ ME!b) 50 <<>;L/;, pH 6.5; :>=A5@20=B. R2 & Ag~Ru(bpy) (G>@=0 :@8H:0), 1 D;0:>=, 9 <;: & A?5F8DVG=89 0=B835= @5:><1V=0=B=89, E. coli), <VG5=89 @CB5=VT28< :><?;5:A>< > 400 <:3/;; 1CD5@ ME! 50 <<>;L/;, pH 6.5; :>=A5@20=B. b) ME! = 2-<>@D>;V=>5B0=AC;LD>=>20 :8A;>B0 CMVIGG Cal1 530B82=89 :0;V1@0B>@ 1 (1V;0 :@8H:0), 2 D;0:>=8 ?> 1.0 <;: !8@>20B:0 :@>2V ;N48=8, =5@50:B82=0 =0 0=B8BV;0 IgG 4> &; 1CD5@; :>=A5@20=B. CMVIGG Cal2 >78B82=89 :0;V1@0B>@ 2 (G>@=0 :@8H:0), 2 D;0:>=8 ?> 1.0 <;: !8@>20B:0 :@>2V ;N48=8, @50:B82=0 =0 0=B8BV;0 IgG 4> &, ?@81;87=> 40 4/<;; 1CD5@; :>=A5@20=B.=01V@114901V@ :>=B@>;L=8E A8@>20B>: PreciControl 4;O 287=0G5==O 0=B8BV; :;0AC IgG 4> F8B><530;>2V@CAC (CMV IgG)49717 - Cytomegalovirus (CMV) V<C=>3;>1C;V= G (IgG) 0=B8BV;0 IVD (4V03=>AB8:0 in vitro), :>=B@>;L=89 <0B5@V0;;O 0=0;V70B>@0 cobas e 411 16 E 1 <; (ml) PC CMVIGG1: 8 D;0:>=V2, ?> 1.0 <; :>=B@>;L=>W A8@>20B:8 2 :>6=><C !8@>20B:0 :@>2V ;N48=8, A;01> ?>78B82=0 =0 0=B8BV;0 IgG 4> & (?@81;87=> 1.5 4/<;); :>=A5@20=B. PC CMVIGG2: 8 D;0:>=V2, ?> 1.0 <; :>=B@>;L=>W A8@>20B:8 2 :>6=><C !8@>20B:0 :@>2V ;N48=8, ?>78B82=0 =0 0=B8BV;0 IgG 4> & (?@81;87=> 25 4/<;); :>=A5@20=B.=01V@250 >7G8==8: C=V25@A0;L=89 /Universal Diluent58237 - CD5@=89 @>7G8==8: 7@07:V2 IVD (4V03=>AB8:0 in vitro ), 02B><0B8G=V/ =0?V202B><0B8G=V A8AB5<8 ;O 0=0;V70B>@0 cobas e 411 2 E 36 <; (ml) Diluent Universal <0T <0@:C20==O Dil. Uni. 2 D;0:>=8, ?> 36 <; 28:>@8AB>2C20=>3> >1 T<C. <VAB: V;:>20 <0B@8FO; :>=A5@20=B d" 0.1 %=01V@205101V@ :>=B@>;L=8E A8@>20B>: PreciControl #=V25@A0;47869 - =>68==V 0=0;VB8 :;V=VG=>W EV<VW IVD (4V03=>AB8:0 in vitro ), :>=B@>;L=89 <0B5@V0;;O 0=0;V70B>@0 cobas e 411 4 E 3 <; (ml) PC U1: 2 D;0:>=8 ?> 2 E 3.0 <; :>=B@>;L=>W A8@>20B:8 (;N4AL:>W) PC U2: 2 D;0:>=8 ?> 2 E 3.0 <; :>=B@>;L=>W A8@>20B:8 (;N4AL:>W)=01V@452!<>;0 4;O AB0=FVW 2>4>?V43>B>2:8, 25 ;.35433 - $V;LB@ 4;O <5E0=VG=>3> >G8I5==O 2>48;O 0=0;V70B>@0 cobas e 411 25 ;VB@V2 C<>;0 4;O 2>4>>G8AB=>W AB0=FVW 20 SDF T 2>4>>G8ICNG8< 5;5<5=B>< 4;O AB0=FVW 2>4>?V43>B>2:8 WSU.HB153!8AB5<=89 @>7G8= 4;O 35=5@0FVW 5;5:B@>EV<VG=8E A83=0;V2 2 V<C=>0=0;V70B>@0E Elecsys, cobas e58237 - CD5@=89 @>7G8==8: 7@07:V2 IVD (4V03=>AB8:0 in vitro ), 02B><0B8G=V/ =0?V202B><0B8G=V A8AB5<8 ;O 0=0;V70B>@0 cobas e 411 6 x 380 <;, A8AB5<=89 1CD5@ $>AD0B=89 1CD5@ 300 <<>;L/;, B@8?@>?V;0<V= 180 <<>;L/;, 45B5@35=B d" 0.1 %, :>=A5@20=B, pH 6.8.=01V@3054 >7G8= Elecsys Sys Wash59058 - 89=89/>G8IC20;L=89 @>7G8= IVD (4V03=>AB8:0 in vitro ) 4;O 02B><0B87>20=8E/ =0?V202B><0B87>20=8E A8AB5<;O 0=0;V70B>@0 cobas e 411 6 x 380 <;, A8AB5<=89 1CD5@ $>AD0B=89 1CD5@ 300 <<>;L/;, B@8?@>?V;0<V= 180 <<>;L/;, 45B5@35=B d" 0.1 %, :>=A5@20=B, pH 6.8.HB2055!8AB5<=89 @>7G8= 4;O G8AB:8 45B5:B>@=>3> 1;>:C, Elecsys, cobas e 59058 - 89=89/>G8IC20;L=89 @>7G8= IVD (4V03=>AB8:0 in vitro ) 4;O 02B><0B87>20=8E/ =0?V202B><0B87>20=8E A8AB5<;O 0=0;V70B>@0 cobas e 411 6 x 380 <; @>7G8=C 4;O >G8I5==O 28<V@N20;L=>W :><V@:8 KOH 176 <<>;L/; (2V4?>2V40T pH 13.2); 45B5@35=B d" 1 %.=01V@2856G8ICNG89 @>7G8= ISE Cleaning Solution/Elecsys SysClean59058 - 89=89/>G8IC20;L=89 @>7G8= IVD (4V03=>AB8:0 in vitro ) 4;O 02B><0B87>20=8E/ =0?V202B><0B87>20=8E A8AB5<;O 0=0;V70B>@0 cobas e 411 5 D;0:>=V2, :>65= <VAB8BL 100 <; ><?>=5=B8: 3V4@>E;>@84 =0B@VN 3 <>;L/; >7G8= 3V?>E;>@8BC =0B@VN (< 2 % 0:B82=>3> E;>@C) ><VH:0=01V@15701V@ @5035=BV2 Elecsys 4;O :V;L:VA=>3> 287=0G5==O 2V;L=>3> 15B0-% (Free hCG)42664 - 01V@ 4;O 287=0G5==O 15B0- O45@=>3> D@03<5=BC E>@V>=VG=>3> 3>=04>B@>?V=C ;N48=8 (15B0-%), V<C=>E5<V;N<V=5AF5=B=89 0=0;V7, IVD (4V03=>AB8:0 in vitro );O 0=0;V70B>@0 cobas e 411 100 B5ABV2 (B0B82 4;O @50:B82V2 <0T <0@:C20==O F BHCG. M V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=>< (?@>7>@0 :@8H:0), 1 D;0:>=, 6.5 <;: V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=><, 0.72 <3/<;; :>=A5@20=B. R1 =B8BV;0 4> 0=B835=C -%~1V>B8=, 1 D;0:>=, 9 <;: 1V>B8=V;L>20=5 <>=>:;>=0;L=5 0=B8BV;> 4> -% (<8H0G5) 3.5 <3/;; D>AD0B=89 1CD5@ 40 <<>;L/;, pH 6.8; :>=A5@20=B. R2 =B8BV;> 4> 2V;L=>3> 0=B835=C -% ~Ru(bpy) (G>@=0 :@8H:0), 1 D;0:>=, 10 <;: >=>:;>=0;L=5 0=B8BV;> 4> 2V;L=>3> 0=B835=C -% (<8H0G5), <VG5=5 :><?;5:A>< @CB5=VN, 1.6 <3/;; D>AD0B=89 1CD5@ 40 <<>;L/;, pH 7.0 :>=A5@20=B.HB4580;V1@C20;L=89 =01V@ 4;O :V;L:VA=>3> 287=0G5==O 2V;L=>3> 15B0-% (free hCG)38266 - %>@V>=VG=89 3>=04>B@>?V= ;N48=8 15B0-AC1>48=8FO (15B0-%) IVD (4V03=>AB8:0 in vitro ), :0;V1@0B>@;O 0=0;V70B>@0 cobas e 411 4 x 1 <; (ml) free hCG Cal1: 2 D;0:>=8, ?> 1.0 <; :0;V1@0B>@0 1 free hCG Cal2: 2 D;0:>=8, ?> 1.0 <; :0;V1@0B>@0 2 V;L=89 -% (@5:><1V=0=B=89, 28@065=89 C HEKa)) C 42>E 4V0?07>=0E :>=F5=B@0FV9 (?@81;87=> 1 /; B0 ?@81;87=> 64 /;) C <0B@8FV A8@>20B:8 :@>2V ;N48=8.=01V@25901V@ @5035=BV2 Elecsys 4;O :V;L:VA=>3> 287=0G5==O 0A>FV9>20=>3> 7 203VB=VABN 1V;:C ?;07<8  (PAPP-A)54304 - V;>:  ?;07<8 (0A>FV9>20=89 7 203VB=VABN) IVD (4V03=>AB8:0 in vitro ), @5035=B ;O 0=0;V70B>@0 cobas e 411 100 B5ABV2 (B0B82 4;O @50:B82V2 <0T <0@:C20==O PAPP A. M V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=>< (?@>7>@0 :@8H:0), 1 D;0:>=, 6.5 <;: V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=><, 0.72 <3/<;; :>=A5@20=B. R1 =B8BV;0 4> PAPP A.~1V>B8=, 1 D;0:>=, 9 <;: V>B8=V;L>20=5 <>=>:;>=0;L=5 0=B8BV;> 4> PAPP A (<8H0G5) 2.0 <3/;; 1CD5@ TRIS 50 <<>;L/;, pH 7.0; :>=A5@20=B. R2 =B8BV;0 4> PAPPA~Ru(bpy) ,(G>@=0 :@8H:0) 1 D;0:>=, 9 <;: >=>:;>=0;L=5 0=B8BV;> 4> PAPP A.(<8H0G5), <VG5=5 :><?;5:A>< @CB5=VN, 1.0 <3/;; D>AD0B=89 1CD5@ 50 <<>;L/;, pH 7.4; :>=A5@20=B.HB4600;V1@C20;L=89 =01V@ 4;O :V;L:VA=>3> 287=0G5==O 0A>FV9>20=>3> 7 203VB=VABN 1V;:C ?;07<8  (PAPP-A)54302 - V;>:  ?;07<8 (0A>FV9>20=89 7 203VB=VABN) IVD (4V03=>AB8:0 in vitro ), :0;V1@0B>@;O 0=0;V70B>@0 cobas e 411 4 x 1 <; (ml) PAPP A Cal1: 2 D;0:>=8 ?> 1.0 <; :0;V1@0B>@0 1 PAPP A Cal2: 2 D;0:>=8 ?> 1.0 <; :0;V1@0B>@0 2 PAPP A (7 ?;0F5=B8 ;N48=8) C 42>E 4V0?07>=0E :>=F5=B@0FV9 (?@81;87=> 75 </; V ?@81;87=> 2500 </;) C <0B@8FV A8@>20B:8 :@>2V ;N48=8=01V@26101V@ :>=B@>;L=8E A8@>20B>: PreciControl 4;O <0@:5@V2 <0B5@8=AL:>3> A:@8=V=3C54018 - =>68==V 3>@<>=8 ;N48=8 IVD (4V03=>AB8:0 in vitro ), :>=B@>;L=89 <0B5@V0;;O 0=0;V70B>@0 cobas e 411 6 3.0 <; % PC MC1: 2 D;0:>=8, ?> 3.0 <; :>=B@>;L=>W A8@>20B:8 % PC MC2: 2 D;0:>=8, ?> 3.0 <; :>=B@>;L=>W A8@>20B:8 % PC MC3: 2 D;0:>=8, ?> 3.0 <; :>=B@>;L=>W A8@>20B:8=01V@262<C=>0=0;V7 4;O :V;L:VA=>3> 287=0G5==O 0;LD01-D5B>?@>B5W=C; cobas e 411, e 601, e 60258348 - ;LD0-D5B>?@>B5W= ($) IVD (4V03=>AB8:0 in vitro ), =01V@, V<C=>E5<V;N<V=5AF5=B=89 0=0;V7 ;O 0=0;V70B>@0 cobas e 411 100 B5ABV2 (B0B82 4;O @50:B82V2 <0T <0@:C20==O AFP. M V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=>< (?@>7>@89 :>2?0G>:), 1 D;0:>=, 6.5 <;: V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=><, 0.72 <3/<;; :>=A5@20=B. R1 =B8-$-0=B8BV;>~1V>B8= (AV@89 :>2?0G>:), 1 D;0:>=, 10 <;: V>B8=V;L>20=5 <>=>:;>=0;L=5 0=B8-$-0=B8BV;> (<8H59) 4.5 <3/;; D>AD0B=89 1CD5@ 100 <<>;L/;, pH 6.0; :>=A5@20=B. R2 =B8-$-0=B8BV;>~Ru(bpy) (G>@=89 :>2?0G>:), 1 D;0:>=, 10 <;: >=>:;>=0;L=5 0=B8-$-0=B8BV;> (<8H0G5), <VG5=5 :><?;5:A>< @CB5=VN 12.0 <3/;; D>AD0B=89 1CD5@ 100 <<>;L/;, pH 6.0; :>=A5@20=B.HB463Elecsys AFP, AFP CalSet II - 01V@ 4;O :0;V1@C20==O :V;L:VA=>3> B5ABC54062 - ;LD0-D5B>?@>B5W=8 ($) IVD (4V03=>AB8:0 in vitro ), :0;V1@0B>@;O 0=0;V70B>@0 cobas e 411 4 x 1 <; (ml) AFP Cal1: 2 D;0:>=8, ?> 1.0 <; :0;V1@0B>@0 1 2 :>6=><C AFP Cal2: 2 D;0:>=8, ?> 1.0 <; :0;V1@0B>@0 2 2 :>6=><C A$ (;N48=8, >B@8<0=89 7 :;VB8==>W :C;LBC@8) C 42>E 4V0?07>=0E :>=F5=B@0FVW (?@81;87=> 5 /<; 01> 6 =3/<; V ?@81;87=> 50 /<; 01> 60 =3/<;) C <0B@8FV V7 A8@>20B:8 :@>2V ;N48=8.=01V@264"5AB 4;O 287=0G5==O D5@8B8=C (100)61078 - $5@@8B8= IVD (4V03=>AB8:0 in vitro ), =01V@, V<C=>E5<V;N<V=5AF5=B=89 0=0;V7;O 0=0;V70B>@0 cobas e 411 100 B5ABV2 (B0B82 4;O @50:B82V2 <0T <0@:C20==O FERR. M V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=>< (?@>7>@89 :>2?0G>:), 1 D;0:>=, 6.5 <;: V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=><, 0.72 <3/<;; :>=A5@20=B. R1 =B8BV;0 4> D5@8B8=C~1V>B8= (AV@89 :>2?0G>:), 1 D;0:>=, 10 <;: V>B8=V;L>20=5 <>=>:;>=0;L=5 0=B8BV;> 4> D5@8B8=C (<8H0G5) 3.0 <3/;; D>AD0B=89 1CD5@ 100 <<>;L/;, pH 7.2; :>=A5@20=B. R2 =B8BV;0 4> D5@8B8=C~Ru(bpy) (G>@=89 :>2?0G>:), 1 D;0:>=, 10 <;: >=>:;>=0;L=5 0=B8BV;> 4> D5@8B8=C (<8H0G5), <VG5=5 :><?;5:A>< @CB5=VN 6.0 <3/;; D>AD0B=89 1CD5@ 100 <<>;L/;, pH 7.2; :>=A5@20=B.HB4650;V1@C20;L=89 =01V@ 4;O :0;V1@C20==O :V;L:VA=>3> 0=0;V7C Elecsys Ferritin / CS Gen.241927 - $5@8B8= IVD (4V03=>AB8:0 in vitro ), :0;V1@0B>@;O 0=0;V70B>@0 cobas e 411 4 x 1.0 <; FERR Cal1: 2 D;0:>=8, ?> 1.0 <; :0;V1@0B>@0 1 % FERR Cal2: 2 D;0:>=8, ?> 1.0 <; :0;V1@0B>@0 2 $5@8B8= (;N4AL:89, ?5GV=:0) C 42>E 4V0?07>=0E :>=F5=B@0FV9 (?@81;87=> 10 <:3/; 01> =3/<; V ?@81;87=> 300 <:3/; 01> =3/<;) C <0B@8FV A8@>20B:8 :@>2V ;N48=8.=01V@266;5:B@>EV<V;N<V=5AF5=B=89 0=0;V7 Elecsys VB0<V= D 7030;L=89 III, 100 B5ABV260922 - '8A;5==V D>@<8 25- 3V4@>:A82VB0<V=C D IVD (4V03=>AB8:0 in vitro ), =01V@, V<C=>E5<V;N<V=5AF5=B=89 0=0;V7;O 0=0;V70B>@0 cobas e 411 100 B5ABV2 (B0B82 4;O @50:B82V2 (M, R1, R2) B0 @50:B828 4;O ?>?5@54=L>W >1@>1:8 (PT1, PT2) <0NBL <0@:C20==O VITDT 3. PT1 50:B82 4;O ?>?5@54=L>W >1@>1:8 1 (1V;0 :@8H:0), 1 D;0:>=, 4 <;: VBV>B@5VB>; 1 3/;, pH 5.5. PT2 50:B82 4;O ?>?5@54=L>W >1@>1:8 2 (AV@0 :@8H:0), 1 D;0:>=, 4 <;: V4@>:A84 =0B@VN 57.5 3/;. M V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=>< (?@>7>@0 :@8H:0), 1 D;0:>=, 6.5 <;: V:@>G0AB8=:8, 2:@8BV AB@5?B02V48=><, 0.72 <3/<;; :>=A5@20=B. R1 VB0<V= D72 O7CNG89 1V;>:Ru/(bpy) (AV@0 :@8H:0), 1 D;0:>=, 9 <;: VG5=89 @CB5=VT< 2VB0<V= D72 O7CNG89 1V;>: 150 <:3/;; 1VAB@8A ?@>?0=>289 1CD5@ 200 <<>;L/;; 0;L1C<V= (;N48=8) 25 3/;; pH 7.5; :>=A5@20=B. R2 253V4@>:A82VB0<V= D~1V>B8= (G>@=0 :@8H:0), 1 D;0:>=, 8.5 <;: V>B8=8;L>20=89 253V4@>:A82VB0<V= D 20 <:3/;; 1VAB@8A ?@>?0=>289 1CD5@ 200 <<>;L/;; pH 8.6; :>=A5@20=B.HB46701V@ 4;O :0;V1@C20==O VB0<V= D 7030;L=89 III54474 - =>68==0 D>@<0 25- 3V4@>:A82VB0<V=C D IVD (4V03=>AB8:0 in vitro ), :0;V1@0B>@;O 0=0;V70B>@0 cobas e 411 4 x 1.0 <; % VITDT 3 Cal1: 2 D;0:>=8, ?> 1.0 <; :0;V1@0B>@0 1 % VITDT 3 Cal2: 2 D;0:>=8, ?> 1.0 <; :0;V1@0B>@0 2 253V4@>:A82VB0<V= D3 C 42>E 4V0?07>=0E :>=F5=B@0FV9 (?@81;87=> 10 =3/<; 01> 25 =<>;L/; B0 ?@81;87=> 70 =3/<; 01> 175 =<>;L/;) C <0B@8FV A8@>20B:8 :@>2V ;N48=8; :>=A5@20=B.=01V@268>=B@>;L O:>ABV V<C=>0=0;V7C VB0<V= D 7030;L=89 III54475 - =>68==0 D>@<0 25- 3V4@>:A82VB0<V=C D IVD (4V03=>AB8:0 in vitro ), :>=B@>;L=89 <0B5@V0;;O 0=0;V70B>@0 cobas e 411 6 x 1.0 <; PC VITDT1: 3 D;0:>=8, ?> 1.0 <; :>=B@>;L=>W A8@>20B:8 !8@>20B:0 :@>2V ;N48=8; :>=A5@20=B. &V;L>25 7=0G5==O ?@81;87=> 20 =3/<; (50 =<>;L/;) % PC VITDT2: 3 D;0:>=8, ?> 1.0 <; :>=B@>;L=>W A8@>20B:8 !8@>20B:0 :@>2V ;N48=8; :>=A5@20=B. &V;L>25 7=0G5==O ?@81;87=> 40 =3/<; (100 =<>;L/;)=01V@269 01>@8 @50:B82V2 4;O 28O2;5==O  2V@CAC ?0?V;><8 16/18 B8?V2 ( :V;L:VA=89 )49994 - 0?V;><02V@CA ;N48=8 (HPV), =C:;5W=>20 :8A;>B0 IVD (4V03=>AB8:0 in vitro ), =01V@, 0=0;V7 =C:;5W=>28E :8A;>B<?;VDV:0FV9=89 B5AB in vitro 2 @568<V @50;L=>3> G0AC 4;O :V;L:VA=>3> 28O2;5==O B0 35=>B8?C20==O 2V@CAC ?0?V;><8 ;N48=8 (16, 18) 2 C@>35=VB0;L=8E <07:0E B0 1V>?B0B0E. !:;04 =01>@C: "  -<V:A-1 "16-18", 3 E 0,28 <; "  -1CD5@-FRT, 3 E 0,3 <; " -?>;V<5@070 Hot Start, 3 E 0,02 <; " 530B82=89 :>=B@>;L, 1,2 <;; " -1CD5@ (!-), 0,5 <; " !B0=40@B :V;L:VA=>3> 287=0G5==O  (QS1 , QS2 , QS3 ), 3 E 0,04 <; 100 B5ABV2HB1070 01>@8 @50:B82V2 4;O 28O2;5==O  F8B><530;>2V@CA ( O:VA=89 )49711 - Cytomegalovirus (CMV), =C:;5W=>20 :8A;>B0 IVD (4V03=>AB8:0 in vitro ), @5035=B<?;VDV:0FV9=89 B5AB 4;O O:VA=>3> 28O2;5==O in vitro  F8B><530;>2V@CAC ;N48=8 (&) 2 :;V=VG=8E <0B5@V0;0E (C@>35=VB0;L=8E <07:0E, 7@07:0E A5GV, A;8=8, FV;L=>W :@>2V ;N48=8) 7 28:>@8AB0==O< 3V1@84=>-D;N>@5AF5=B=>W 45B5:FVW 2 @50;L=><C G0AV. !:;04 =01>@C: "  -AC<VH-1-FRT & 1,2 1 ?@>1V@:0 "  -AC<VH-2-FRT 0,3 2 ?@>1V@:8 " >;V<5@070 (TaqF) 0,03 2 ?@>1V@:8 " ><?;5:A ?>78B82=>3> :>=B@>;N 0,2 1 ?@>1V@:0 " 1CD5@  0,5 1 ?@>1V@:0 " 530B82=89 :>=B@>;L 1,2 1 ?@>1V@:0 " =CB@VH=V9 :>=B@>;L-FL 1,0 1 ?@>1V@:0 100 B5ABV2HB1071 01>@8 @50:B82V2 4;O 28O2;5==O  B>:A>?;07<8 ( O:VA=89 )52428 - C:;5W=>2V :8A;>B8 B>:A>?;07<8 IVD (4V03=>AB8:0 in vitro ), =01V@, 0=0;V7 =C:;5W=>28E :8A;>B"5AB 4;O 0<?;VDV:0FVW =C:;5W=>28E :8A;>B in vitro 4;O O:VA=>3> 28O2;5==O  Toxoplasma gondii 2 :;V=VG=><C <0B5@V0;V (;59:>F8B8 FV;L=>W ?5@8D5@8G=>W :@>2V, 0CB>?AV9=89 <0B5@V0;, A?8==><>7:>20 @V48=0, 0<=V>B8G=0 @V48=0) 70 4>?><>3>N 3V1@84870FV9=>- D;C>@5AF5=B=>W 45B5:FVW 2 @568<V @50;L=>3> G0AC. A:;04 =01>@C: "  -<V:A-1-FRT T.gondii 0.6 1 BN18: "  -<V:A-2-FRT 0.3 1 BN18: " >;V<5@070 (TaqF) 0.03 2 BN18:0 " Pos Control  T. gondii /STI (!+) 0.1 1 BN18: " -1CD5@ 0.5 1 BN18: " 530B82=89 :>=B@>;L (C-) 1.2 1 BN18: " =CB@VH=V9 :>=B@>;L STI-87 (IC) 1.0 1 BN18: 50 B5ABV2HB1072 01>@8 @50:B82V2 4;O 28O2;5==O  2V@CAC ?@>AB>3> 35@?5A0 1/2B8?C ( O:VA=89 )49539 - V@CA ?@>AB>3> 35@?5AC 1 V 2 (HSV1 V 2), =C:;5W=>20 :8A;>B0 IVD (4V03=>AB8:0 in vitro ), =01V@, 0=0;V7 =C:;5W=>28E :8A;>B (NAT)01V@ 4;O   2 @50;L=><C G0AV 4;O O:VA=>3> 28O2;5==O 2V@CAC 35@?5AC  B0  B8?C  HSV I/II Typing Real-TM !:;04 =01>@C: " PCR-mix-1-FRT, 1,2 <;; " PCR-mix-2, 2 x 0,3 <;; " >;V<5@070 TaqF 2 x 0,03 <;; " Pos C+, 0,2 <;; " 530B82=89 :>=B@>;L C-, 1,2 <;;* " =CB@VH=V9 :>=B@>;L IC, 1,0 <;;** " DNA-buffer, 0,5 <;; 100 B5ABV2HB873 01>@8 @50:B82V2 4;O 28O2;5==O  E;0<V4V9 ( O:VA=89 )47320 - Chlamydia trachomatis, =C:;5W=>20 :8A;>B0 IVD (4V03=>AB8:0 in vitro ), =01V@, 0=0;V7 =C:;5W=>28E :8A;>B01V@ @5035=BV2 4;O 4V03=>AB8:8 Chlamydia trachomatis <5B>4><   C @50;L=><C G0AV. !:;04 =01>@C: "  -AC<VH-1-FRT Chlamydia trachomatis 1,2 1 ?@>1V@:0 "  -AC<VH-2-FRT 0,3 2 ?@>1V@:8 " >;V<5@070 (TaqF) 0,03 2 ?@>1V@:8 " ><?;5:A ?>78B82=>3> :>=B@>;N 0,2 1 ?@>1V@:0 " CD5@  0,5 1 ?@>1V@:0 " 530B82=89 :>=B@>;L 1,2 1 ?@>1V@:0 " =CB@VH=V9 :>=B@>;L-FL 1,0 1 ?@>1V@:0 100 B5ABV2.HB874 01>@8 @50:B82V2 4;O 28O2;5==O  2V@CAC ?HB59= -0@@0 ( O:VA=89 )49653 - V@CA Epstein-Barr (EBV), =C:;5W=>20 :8A;>B0 IVD (4V03=>AB8:0 in vitro ), =01V@, 0=0;V7 =C:;5W=>28E :8A;>B"5AB C @50;L=><C G0AV 4;O O:VA=>3> B0 :V;L:VA=>3> 28O2;5==O 2V@CAC ?HB59=0-0@@0. !:;04 =01>@C: " V;L:VABL EBV Real-TM:>A8;5==O 2 @50;L=><C G0AV 2 E 0,6 <; "  -AC<VH-1 2 E 0,3 <; "  -1CD5@ FRT 2 E 0,03 <; " "-1CD5@ -?>;V<5@078 30@OG>3> AB0@BC 0,5 <; " 530B82=89 :>=B@>;L C- 1,2 <; " EBV DNA&IC Glob C+ 2 E 0,1 <; " =CB@VH=V9 :>=B@>;L IC 2 E 0,6 <; " AB0=40@B=0  EBV/IC glob > QSG1 0,2 <; > QSG2 0,2 <; 100 B5ABV2HB87501V@ 4;O 284V;5==O  52521 :AB@0:FVO/V7>;OFVO =C:;5W=>28E :8A;>B, =01V@ IVD (4V03=>AB8:0 in vitro )01V@ 4;O 5:AB@0:FVW =C:;5W=>28E :8A;>B "DNA-sorb-A" ?@87=0G0TBLAO 4;O V7>;OFVW B0 >G8I5==O  2V4 C@>35=VB0;L=8E <07:V2, A5GV, ?@>AB0B8G=>W @V48=8 B0 V=H8E 1V>;>3VG=8E <0B5@V0;V2. !:;04 =01>@C: " >7G8= 4;O ;V78AC 2 x 15 <;; " @><82=89 @>7G8=, 2 x 50 <;; " !>@15=B, 2 x 1,0 <;; " ;N5=B , 2 x 5 <;. " "@0=A?>@B=5 A5@54>28I5, 2 x 15 <;. 100 B5ABV2.HB107601V@ @5035=BV2 4;O 284V;5==O 52521 - :AB@0:FVO/V7>;OFVO =C:;5W=>28E :8A;>B, =01V@ IVD (4V03=>AB8:0 in vitro )01V@ 4;O 5:AB@0:FVW =C:;5W=>28E :8A;>B DNA-Sorb-B ?@87=0G5=89 4;O V7>;OFVW B0 >G8I5==O  2V4 ?;07<8, A8@>20B:8, FV;L=>W :@>2V, A?8@BC, 0<=V>B8G=>W @V48=8, B:0=8=, A5GV, 5:A:@5<5=BV2, 1@>=EV0;L=8E 0A?V@0BV2 B0 V=H8E 1V>;>3VG=8E <0B5@V0;V2. !:;04 =01>@C: " >7G8= 4;O ;V78AC 1 x 30 <;l; " @><82=89 @>7G8= 1, 1 x 30 <;; " @><82=89 @>7G8= 2, 1 x 100 <;; " !>@15=B 2 x 1,25 <;; " ;N5=B  2 x 5 <;. 100 B5ABV2.HB27701V@ @5035=BV2 4;O 4V03=>AB8:8 <V:>?;07<8 E><V=VA (Mycoplasma hominis) <5B>4><   C @50;L=><C G0AV63422 - V:@>?;07<8 E><V=VA, =C:;5W=>20 :8A;>B0 IVD (4V03=>AB8:0 in vitro ), =01V@, <5B>4 =C:;5W=>2>W :8A;>B8 ()"5AB 4;O O:VA=>3> 28O2;5==O Mycoplasma hominis 2 C@>35=VB0;L=8E <07:0E, A5GV, ?@>AB0B8G=V9 @V48=V B0 V=H8E 1V>;>3VG=8E <0B5@V0;0E <5B>4><   C @50;L=><C G0AV. !:;04 =01>@C: >4C;L !1: 01V@ 4;O   C @50;L=><C G0AV '0AB8=0 ! 2  Mycoplasma hominis TM :>A8;5==O 2 @50;L=><C G0AV. "  -AC<VH-1-FRT, 1,2 <;; "  -AC<VH-2, 2 E 0,3 <;; " >;V<5@070 TaqF, 2 E 0,03 <;; " >7 C+, 0,2 <;; " 530B82=89 :>=B@>;L C-, 1,2 <;;* "  2=CB@VH=L>3> :>=B@>;N, 1,0 <;;** " -1CD5@, 0,5 <;; VAB8BL 100 B5ABV2.HB878"5AB-A8AB5<0 V<C=>D5@<5=B=0 4;O 28O2;5==O 0=B8BV; 4> :;0AV2 Ig G B0 IgM "reponema pallidum DIA-Ig G - IgM Trep (192 ;C=>:)51815 - Treponema pallidum, 0=B8BV;0 :;0AC V<C=>3;>1C;V= G (IgG) B0 V<C=>3;>1C;V= M (IgM), =01V@, V<C=>D5@<5=B=89 0=0;V7 ($)192 4>A;V465==O <C=>A>@15=B >;VAB8@>;>289 ?;0=H5B 2 ?0:5BV 7 ;0<V=>20=>3> 0;N<V=VN 7 70<:>< Ziploc 2 ;C=:0E O:>3> A>@1>20=V @5:><1V=0=B=V 1V;:8 "@@ 15, "@@ 17, "@@ 41 B0 "@@ 47  0=0;>38 0=B835=V2 T. pallidum- >=F5=B@0B :>= N30BC (11x) >=>:;>=0;L=V 0=B8BV;0 4> IgG B0 Ig ;N48=8, :>= N3>20=V 7 ?5@>:A8407>N E@>=C. >=A5@20=B: 0.2% ProClin"300. '5@2>=0 7 =57=0G=>N >?0;5AF5=FVTN @V48=0- >78B82=89 :>=B@>;L G8I5=V V<C=>3;>1C;V=8 ;N48=8, A?5F8DVG=V 4> T.pallidum. >=A5@20=B: 0.2% ProClin"300.!2VB;>-6>2B0 7 =57=0G=>N >?0;5AF5=FVTN @V48=0- 530B82=89 :>=B@>;L =0:B82>20=0 A8@>20B:0 :@>2V ;N48=8, O:0 =5 <VAB8BL HsAg, 0=B835= @24 -1 B0 0=B8BV;0 4> 2V@CAC 35?0B8BC !, -1 V -2, V T.pallidum. >=A5@20=B: 0.2% ProClin"300.!2VB;>-6>2B0 7 =57=0G=>N >?0;5AF5=FVTN @V48=0. - >=F5=B@0B @>7G8=C 4;O ?@><820==O (26E)>=F5=B@0B D>AD0B=>-A>;L>2>3> 1CD5@C, <VAB8BL 45B5@35=B. 5710@2=0 >?0;5AFNNG0 @V48=0, 4>?CA:0TBLAO @>7H0@C20==O B0 28?04V==O :@8AB0;VG=>3> >A04C, I> @>7G8=OTBLAO ?@8 =03@V20==V- >7G8= 4;O @>72545==O A8@>20B>: $>AD0B=>-A>;L>289 1CD5@, <VAB8BL 45B5@35=B, :075W=>2C D@0:FVN 1V;:V2 <>;>:0, 1;>:-:><?>=5=B8, 10@2=8: V :>=A5@20=B 0.4% ProClin"300. $V>;5B>20 >?0;5AFNNG0 @V48=0- >7G8= 4;O @>72545==O :>= N30BC $>AD0B=>-A>;L>289 1CD5@, <VAB8BL 45B5@35=B, :075W=>2C D@0:FVN 1V;:V2 <>;>:0, 1;>:-:><?>=5=B8, 10@2=8: V :>=A5@20=B 0.4% ProClin"300. '5@2>=0 >?0;5AFNNG0 @V48=0- "-AC1AB@0B3,3 ,5,5 -B5B@0<5B8;15=7848= 2 @>7G8=V, I> <VAB8BL ?5@5:8A 2>4=N. @>7>@0 15710@2=0 @V48=0- !B>?-@5035=B >7G8= AV@G0=>W :8A;>B8. @>7>@0 15710@2=0 @V48=0- ;59:0 ?;V2:0HB479"5AB-A8AB5<0 V<C=>D5@<5=B=0 4;O 28O2;5==O ?>25@E=52>3> 0=B835=C 2V@CAC 35?0B8BC  (HBsAg) DIA-HBsAg (192 4>A;.), 01> 5:2V20;5=B48319 - V@CA 35?0B8BC B, ?>25@E=5289 0=B835= IVD (4V03=>AB8:0 in vitro ), =01V@, V<C=>D5@<5=B=89 0=0;V7 ($)"5AB-A8AB5<8 <0NBL 70157?5GC20B8 <>6;82VABL 28O2;5==O ?>25@E=52>3> 0=B835=C 2V@CAC 35?0B8BC (HBsAg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sAg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iploc, 2 ;C=:0E O:>3> A>@1>20=V <>=>:;>=0;L=V 0=B8BV;0 4> HBsAg2. 1  >=F5=B@0B :>= N30BC !1 (11x) >=>:;>=0;L=V 0=B8BV;0 4> HBsAg, :>= N3>20=V 7 1V>B8=><. >=A5@20=B: 0.2% ProClin"300.!8=O 7 =57=0G=>N >?0;5AF5=FVTN @V48=0 3. 2  >=F5=B@0B :>= N30BC !2 (11x) !B@5?B02V4V=, :>= N3>20=89 7 ?5@>:A8407>N E@>=C.>=A5@20=B:0.1% 5-1@><>-5-=VB@>-1,3-4V>:A0= (BND).><0@0=G520 7 =57=0G=>N >?0;5AF5=FVTN @V48=0 4.   >78B82=89 :>=B@>;L =0:B82>20=0 A8@>20B:0 :@>2V ;N48=8, O:0 <VAB8BL HsAg. >=A5@20=B: 0.2% ProClin"300.!2VB;>-6>2B0 7 =57=0G=>N >?0;5AF5=FVTN @V48=0 5.   530B82=89 :>=B@>;L =0:B82>20=0 A8@>20B:0 :@>2V ;N48=8, O:0 =5 <VAB8BL HsAg, 0=B835= @24 -1 B0 0=B8BV;0 4> 2V@CAC 35?0B8BC !, -1 V -2, V T.pallidum.>=A5@20=B: 0.2% ProClin"300. !2VB;>-6>2B0 7 =57=0G=>N >?0;5AF5=FVTN @V48=0. 6.    >=F5=B@0B @>7G8=C 4;O ?@><820==O (26E)>=F5=B@0B D>AD0B=>-A>;L>2>3> 1CD5@C, <VAB8BL 45B5@35=B. 5710@2=0 >?0;5AFNNG0 @V48=0, 4>?CA:0TBLAO @>7H0@C20==O B0 28?04V==O :@8AB0;VG=>3> >A04C, I> @>7G8=OTBLAO ?@8 =03@V20==V 1E110 <;7.  1  >7G8= 4;O @>72545==O :>= N30BC !1$>AD0B=>-A>;L>289 1CD5@, <VAB8BL 45B5@35=B, :075W=>2C D@0:FVN 1V;:V2 <>;>:0, 1;>:-:><?>=5=B8, 10@2=8: V :>=A5@20=B 0.4% ProClin"300.'5@2>=0 >?0;5AFNNG0 @V48=0 8.  2  >7G8= 4;O @>72545==O :>= N30BC !2$>AD0B=>-A>;L>289 1CD5@, <VAB8BL 45B5@35=B V :>=A5@20=B 0.4% ProClin"300.5710@2=0 >?0;5AFNNG0 @V48=0 9. "-AC1AB@0B 3,3 ,5,5 -B5B@0<5B8;15=7848= 2 @>7G8=V, I> <VAB8BL ?5@5:8A 2>4=N. @>7>@0 15710@2=0 @V48=0 10. !B>?-@5035=B >7G8= AV@G0=>W :8A;>B8. @>7>@0 15710@2=0 @V48=0 11. ;59:0 ?;V2:0 #AV =528:>@8AB0=V @5035=B8 B5AB-A8AB5<8 715@V30NBLAO 2 IV;L=> 70:@8BV9 ?5@28==V9 C?0:>2FV ?@8 (2-8)! 2 70E8I5=><C 2V4 A2VB;0 <VAFV 2?@>4>26 B5@<V=C ?@840B=>ABV B5AB-A8AB5<8. E>4V ?@>2545==O 0=0;V7C ?>28==0 1CB8 <>6;82VABL 715@V30==O @5035=BV2 B5AB-A8AB5<8 ?@>BO3>< =5 <5=H5 8 3>48= ?@8 B5<?5@0BC@V (18-25)! 2 70E8I5=><C 2V4 A2VB;0 <VAFV. 030;L=89 B5@<V= ?@840B=>ABV B5AB-A8AB5<8 ?>28=5= 1CB8 =5 <5=H5 18 <VAOFV2. 0O2=VABL <>6;82>ABV B@0=A?>@BC20==O B5AB-A8AB5<8 70 B5<?5@0BC@8 (9-25)! ?@>BO3>< 45AOB8 4V1.HB480"5AB-A8AB5<0 V<C=>D5@<5=B=0 4;O 28O2;5==O 0=B8BV; 4> 2V@CAC 35?0B8BC ! DIA-HCV- (192 4>A;.), 01> 5:2V20;5=B48365 - V@CA 35?0B8BC C, 7030;L=V 0=B8BV;0 IVD (4V03=>AB8:0 in vitro ), =01V@, V<C=>D5@<5=B=89 0=0;V7 ($)192 4>A;V465==O 1. <C=>A>@15=B >;VAB8@>;>289 ?;0=H5B 2 ?0:5BV 7 ;0<V=>20=>3> 0;N<V=VN 7 70<:>< Ziploc, 2 ;C=:0E O:>3> A>@1>20=V @5:><1V=0=B=V 1V;:8 NS3, NS4, NS5 B0 <>70WG=89 1V;>: GST-CNab (core, NS3, NS4a, NS4b)  0=0;>38 0=B835=V2 2V@CAC 35?0B8BC !: core, NS3, NS4, NS52.   >=F5=B@0B :>= N30BC (11x) >=>:;>=0;L=V 0=B8BV;0 4> IgG B0 Ig ;N48=8, :>= N3>20=V 7 ?5@>:A8407>N E@>=C. >=A5@20=B: 0.2% ProClin"300. '5@2>=0 7 =57=0G=>N >?0;5AF5=FVTN @V48=0. 3.   >78B82=89 :>=B@>;L G8I5=V V<C=>3;>1C;V=8 ;N48=8, A?5F8DVG=V 4> 2V@CAC 35?0B8BC !. >=A5@20=B: 0.2% ProClin"300.!2VB;>-6>2B0 7 =57=0G=>N >?0;5AF5=FVTN @V48=0. 4.   530B82=89 :>=B@>;L =0:B82>20=0 A8@>20B:0 :@>2V ;N48=8, O:0 =5 <VAB8BL HsAg, 0=B835= @24 -1 B0 0=B8BV;0 4> 2V@CAC 35?0B8BC !, -1 V -2, V T.pallidum. >=A5@20=B: 0.2% ProClin"300.!2VB;>-6>2B0 7 =57=0G=>N >?0;5AF5=FVTN @V48=0. 5.    >=F5=B@0B @>7G8=C 4;O ?@><820==O (26E)>=F5=B@0B D>AD0B=>-A>;L>2>3> 1CD5@C, <VAB8BL 45B5@35=B. 5710@2=0 >?0;5AFNNG0 @V48=0, 4>?CA:0TBLAO @>7H0@C20==O B0 28?04V==O :@8AB0;VG=>3> >A04C, I> @>7G8=OTBLAO ?@8 =03@V20==V 6.  !  >7G8= 4;O @>72545==O A8@>20B>:$>AD0B=>-A>;L>289 1CD5@, <VAB8BL 45B5@35=B, :075W=>2C D@0:FVN 1V;:V2 <>;>:0, 1;>:-:><?>=5=B8, 10@2=8: V :>=A5@20=B 0.4% ProClin"300.$V>;5B>20 >?0;5AFNNG0 @V48=0 7.    >7G8= 4;O @>72545==O :>= N30BC$>AD0B=>-A>;L>289 1CD5@, <VAB8BL 45B5@35=B, :075W=>2C D@0:FVN 1V;:V2 <>;>:0, 1;>:-:><?>=5=B8, 10@2=8: V :>=A5@20=B 0.4% ProClin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carbon - B5AB (500 287=0G5=L)51819 -Treponema pallidum reagin antibody IVD (4V03=>AB8:0 in vitro ), =01V@, @50:FVO 03;NB8=0FVWRPR-carbon-B5AB - =5B@5?>=5<=89 03;NB8=0FV9=89 B5AB 4;O O:VA=>3> B0 =0?V2:V;L:VA=>3> 28O2;5==O ?;07<>28E @503V=V2 2 A8@>20BFV ;N48=8. 1. 5035=B 1. C3V;L=0 ACA?5=7VO, 5 <; (1 D;.) 2. 5035=B 2. >78B82=89 :>=B@>;L, 0.5 <; (1 D;.) 3. 5035=B 3. 530B82=89 :>=B@>;L, 0.5 <; (1 D;.) 4. 0;8G:8 4;O @>7<VHC20==O A8@>20B>: (250 HB.) 5. "5AB>289 A;094 5 HB. D5:B ?@>7>=8: 5D5:B ?@>7>=8 =5 A?>AB5@V30TBLAO 4> B8B@C e"1/128. 040B8 30@0=BV9=89 ;8AB 2V4 28@>1=8:0 01> >DVFV9=>3> ?@54AB02=8:0.?0:182V>EV<VG=0 :>=B@>;L=0 A8@>20B:0 (Human)  (5 x 5 <;)47869 - =>68==V 0=0;VB8 :;V=VG=>W EV<VW IVD, :>=B@>;L=89 <0B5@V0; AV :><?>=5=B8 ;N4AL:>3> ?>E>465==O =530B82=V ?> HBs-0=B835=C, ?> 0=B8BV;0E ?@>B8 HCV V HIV. !8@>20B:0 4>72>;OT ?@>2>48B8 :>=B@>;L B0:8E ?>:07=8:V2: 0=3V>B5=78= ?5@5B2>@NNG89 D5@<5=B, :8A;0 D>AD0B070, 0;L1C<V=, ;C6=0 D>AD0B070, ", -0<V;070, -0<V;070 ?0=:@50B8G=0, !", 1V;V@C1V= 7030;L=89 B0 ?@O<89, :0;LFV9, E;>@848, E>;5AB5@8=, E>;5AB5@8= HDL, E>;5AB5@8= LDL, E>;V= 5AB5@070, :@50B8=:V=070, :@50B8=V=, 3;N:>70, ", 70;V7>, ;0:B0B, ;V?070, , <03=V9, D>AD>@, :0;V9, 1V;>: (7030;L=89), =0B@V9, B@83;VF5@848, A5G>28=0, A5G>20 :8A;>B0, F8=:HB183V>EV<VG=0 :>=B@>;L=0 A8@>20B:0 (Human)  (5 x 5 <;)47869 - =>68==V 0=0;VB8 :;V=VG=>W EV<VW IVD, :>=B@>;L=89 <0B5@V0; AV :><?>=5=B8 ;N4AL:>3> ?>E>465==O =530B82=V ?> HBs-0=B835=C, ?> 0=B8BV;0E ?@>B8 HCV V HIV. !8@>20B:0 4>72>;OT ?@>2>48B8 :>=B@>;L B0:8E ?>:07=8:V2: 0=3V>B5=78= ?5@5B2>@NNG89 D5@<5=B, :8A;0 D>AD0B070, 0;L1C<V=, ;C6=0 D>AD0B070, ", -0<V;070, 0<V;070 ?0=:@50B8G=0, !", 1V;V@C1V= 7030;L=89 B0 ?@O<89, :0;LFV9, E;>@848, E>;5AB5@8=, E>;5AB5@8= HDL, E>;5AB5@8= LDL, E>;V= 5AB5@070, :@50B8=:V=070, :@50B8=V=, 3;N:>70, ", 70;V7>, ;0:B0B, ;V?070, , <03=V9, D>AD>@, :0;V9, 1V;>: (7030;L=89), =0B@V9, B@83;VF5@848, A5G>28=0, A5G>20 :8A;>B0, F8=:.HB184%C<0B@>;  :>=B@>;L=0 A8@>20B:047869 =>68==V 0=0;VB8 :;V=VG=>W EV<VW IVD (4V03=>AB8:0 in vitro), :>=B@>;L=89 <0B5@V0;V>DV;V7>20=0 C=V25@A0;L=0 :>=B@>;L=0 A8@>20B:0, ?@83>B>20=0 =0 >A=>2V 18G0G>W A8@>20B:8, 7 ?5@52V@5=8<8 ?>:07=8:0<8, 4;O :>=B@>;N B>G=>ABV @CG=8E B0 02B><0B8G=8E <5B>48: (=>@<0;L=V @V2=V ?>:07=8:V2), D0AC20==O =5 <5=H5 6E5 <;C?185%C<0B@>;  :>=B@>;L=0 A8@>20B:047869 =>68==V 0=0;VB8 :;V=VG=>W EV<VW IVD (4V03=>AB8:0 in vitro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aVbiiiiijZjvkpp"p$p&p,ppq0yA@ABADAHAJAAATBVBhC F"F(F*F,F.FһuһuһuhA"*CJOJQJ^JaJhA"*CJOJQJ^JaJ(hehA"*CJOJQJ^JaJmHsH(hehA"*CJOJQJ^JaJmHsHhehA"*CJaJmHsHhA"*CJaJ$hEhA"*CJaJmHnHsHtHhA"*CJaJ$hEhA"*CJaJmHnHsHtH.fûԯûԯwohcWhhW6mH"sH" h?/M6 h1|h?/Mh1|h?/M5hh?/M5mH"sH"hh?/MmH"sH" hRr7h?/Mh@h?/MCJaJhe7h?/MCJaJmH"sH"h?/MCJaJmH"sH"h?/MCJaJ h* h?/MCJOJQJ^JaJh* h?/MCJaJh* h?/M6CJ\]aJ hB/h?/MhB/h?/MCJaJbbbbbbb(cm[[OO>>$$7$8$H$Ifa$gd@R $$Ifa$gd@R$$9DIf]a$gd@Rkd$$Ifl4F<$<` t06    44 laYytN%(cFcHc\cvc~ccccccdddfehe>f@f $ 9!a$gdW $`a$gd?/M $^a$gdN%$ h`a$gd?/MFf4 $$Ifa$gd@R$$9DIf]a$gd@R$$7$8$H$Ifa$gd@R>f@fBfDfHfJfNfPfTfVf\f^fh;jh;UhWhKw6mH"sH"hhW5mH"sH" @fBfFfHfLfNfRfTfXfZf\f^fgdgdW 501h:p. A!n"S#7$7% 801h0:pA .!7"7#S$n% $$If!vh#v#v#vE #v #v3#vI#v:V l t06,59BBp<ytp7kd$$Ifl֞V$^/37=bbBB t0644 lBBap<ytp7$$If!vh#v#v#vE #v #v3#vI#v:V l t0659p<ytp7kd$$Ifl֞V$^/37="" t0644 lap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kd$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l,  t06,,599BBp<ytp7#kd* $$Ifl,֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kdr $$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kd$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l,  t06,,599BBp<ytp7#kd$$Ifl,֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l,  t06,,599BBp<ytp7#kdJ$$Ifl,֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kd$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kd$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kd" $$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kdj#$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l,  t06,,599BBp<ytp7#kd&$$Ifl,֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kd)$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kdB-$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l,  t06,,599BBp<ytp7#kd0$$Ifl,֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kd3$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kd7$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kdb:$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l,  t06,,599BBp<ytp7#kd=$$Ifl,֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kd@$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l,  t06,,599BBp<ytp7#kd:D$$Ifl,֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kdG$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kdJ$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kdN$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l,  t06,,599BBp<ytp7#kdZQ$$Ifl,֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kdT$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kdW$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kd2[$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kdz^$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kda$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kd e$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kdRh$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kdk$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l,  t06,,599BBp<ytp7#kdn$$Ifl,֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kd*r$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kdru$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kdx$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l,  t06,,599BBp<ytp7#kd|$$Ifl,֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kdJ$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kd$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kdڅ$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kd"$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kdj$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kd$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kd$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kdB$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kd$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kdҜ$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kd$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kdb$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kd$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kd$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l,  t06,,599BBp<ytp7#kd:$$Ifl,֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kd$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kdʳ$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kd$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kdZ$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l,  t06,,599BBp<ytp7#kd$$Ifl,֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kd$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l,  t06,,599BBp<ytp7#kd2$$Ifl,֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kdz$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l,  t06,,599BBp<ytp7#kd$$Ifl,֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kd $$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kdR$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kd$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7!$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,,599BBp<ytp7#kd$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,599BBp<ytp7#kd*$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,599BBp<ytp7#kdl$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,599BBp<ytp7#kd$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,599BBp<ytp7#kd$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,599BBp<ytp7#kd2$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7$$If!vh#v#v#vE #v #v3#vI#v:V l,  t06,599BBp<ytp7#kdt$$Ifl,֞V$^/37=bbbB  t0644 lBBap<ytp7$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,599BBp<ytp7#kd$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,599BBp<ytp7#kd$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7$$If!vh#v#v#vE #v #v3#vI#v:V l,  t06,599BBp<ytp7#kd:$$Ifl,֞V$^/37=bBbB  t0644 lBBap<ytp7$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,599BBp<ytp7#kd|$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7$$If!vh#v#v#vE #v #v3#vI#v:V l,  t06,599BBp<ytp7#kd$$Ifl,֞V$^/37=bBbB  t0644 lBBap<ytp7$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,599BBp<ytp7#kd$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,599BBp<ytp7#kdB$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,599BBp<ytp7#kd$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,599BBp<ytp7#kd$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,599BBp<ytp7#kd $$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7$$If!vh#v#v#vE #v #v3#vI#v:V l t06,599BBp<ytp7kdJ$$Ifl֞V$^/37=bBbB t0644 lBBap<ytp7$$If!vh#v#v#vE #v #v3#vI#v:V l t06,599BBp<ytp7kdP$$Ifl֞V$^/37=bBbB t0644 lBBap<ytp7$$If!vh#v#v#vE #v #v3#vI#v:V l t06,599BBp<ytp7kdV$$Ifl֞V$^/37=bBbB t0644 lBBap<ytp7$$If!vh#v#v#vE #v #v3#vI#v:V l  t06,599BBp<ytp7#kd\$$Ifl֞V$^/37=bBbB  t0644 lBBap<ytp7$$IfY!vh#vO#v#v:V l4 t06+5aYytN%$$IfY!v h#vO#v#v#v#v#v#v#v#v #v #v #v #v :V l4 t06+,, 55 5 5 5 5 aYytN%kd1$$Ifl4" < {?!$*l-E15Q9<  t06444444 laYytN%b/   666666666666666666666666666666666666666666 66666666 66666666666 666666666666>6666666666666666666666666666666666666666666666666666628 0@P`p28 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~PJ_HmHnHsHtHT`T E1KG=K9*$%B*CJPJ_HaJmHphsHtHj@j )a0 03>;>2>: 1$<@&*5CJ KHOJPJQJ\aJ mHsHtHh@h ,eX 03>;>2>: 2$ *$@&^ #5B*CJOJQJ\mH"phsH"p@p 7nL 03>;>2>: 3$<@&/5B*CJOJPJQJ\aJmH"phsH"tH"BA B A=>2=>9 H@8DB 0170F0Xi@X 01KG=0O B01;8F04 l4a .k . 0 5B A?8A:0 `o` ae003>;>2>: 1 =0:'5B*CJ KHOJQJ\^JaJ ph^o^ 7nL03>;>2>: 3 =0:&5CJOJQJ\^JaJmH"sH"tH"pop 7nL0A=>2=>9 B5:AB A >BABC?>< =0:CJOJQJ^J_HaJtH^o!^ 7nL0!B0=40@B=K9 HTML =0:OJQJ^J_HmH"sH"tH@o1@ P0V?5@?>A8;0==O >*B*phToAT 0AA=>2=>9 B5:AB =0:B*CJPJaJphP>@bP 0720=85 $xCJOJPJ QJ^JaJ<B@b< 0AA=>2=>9 B5:ABx,/@ar, !?8A>:^JR"@R 0720=85 >1J5:B0  $xx 6]^J4O4 >:06G8: $^JxC@x 7nL0A=>2=>9 B5:AB A >BABC?>< x1$^B*OJPJQJ^JphtHe@ 7nL0!B0=40@B=K9 HTML72( Px 4 #\'*.25@9-B*CJOJPJQJ^JaJmH"phsH"tHp@p 7nL0 170F A?8A:0d^-B*CJOJPJQJ^JaJmH"phsH"tH xOx 7nLA=>2=>9 B5:AB A >BABC?>< 21n/ `na$B*nHphtH:O:  <VAB B01;8FV $HOH 03>;>2>: B01;8FVa$5\pp }- !5B:0 B01;8FK7:V 0 LL "05@E=89 :>;>=B8BC; ! %ho!h !05@E=89 :>;>=B8BC; =0:!B*CJPJaJmHphsHtHJ 2J $086=89 :>;>=B8BC; # %foAf #086=89 :>;>=B8BC; =0:!B*CJPJaJmHphsHtHJ@RJ &70 "5:AB 2K=>A:8%CJOJQJ^JaJ^oa^ %70"5:AB 2K=>A:8 =0:!B*CJOJPJQJ^JaJphq !;2250,baiaagaaboqcaaadyqqaaaxxbaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaO Kwp!5B:0 B01;8FK107:V(0(CJPJaJtH PoP *E057 8=B5@20;0 =0:CJKHPJ aJtH"\`\ )E0 57 8=B5@20;0**$1$ CJKHPJ _HaJmHsHtH"R^@R k0 1KG=K9 (251)+dd*$[$\$ B*phZoZ eX03>;>2>: 2 =0:"5CJOJPJQJ\aJmH"sH"vR@v .eXA=>2=>9 B5:AB A >BABC?>< 2-$*$`a$B*mH"phsH"lol -eX A=>2=>9 B5:AB A >BABC?>< 2 =0:CJPJaJmH"sH"PK![Content_Types].xmlN0EH-J@%ǎǢ|ș$زULTB l,3;rØJB+$G]7O٭VCWNIA!ޝ}7/݉%BR7Hw9!p<Ǥፉ.EB\ /T*Y>,cy'$gC."Vso+C1OǓt}8>V3mBb%DWs'O''Gw ~lh;UM!DzŬ;C K^ysJJ1KRμ)~.ک/ Y\n9?[]67)qnpJOF$ w;fCLL&׸m%]V%z-{ v8Ҩm-.xo(-ms~ۜ|s>Ͼ%O04h=یщ!eƌ\f :C*OiIA 64HpUa7 UO3 d:(fA@٣>N"Hhp&hA38 )SUUR'V5&HM.6xpyn,ބ!h^^Z4~0#w,,& g"Ic힍Q)˕C6%^+Hk!$A*#.D)irdq8Y^}q~C>Np%uJx?+al|zf[Ux5b>c!:M (MkIVEpYPҍN2$ÿ -.h۴"P6T{T 6]u̒VhVnR+n;)ȔbL X6Y`+qB]( 0H1$6_[s)k8Tm Aa?R d ڒɾ0{eRF& Ī't\{BHuM6`pGϽO+!XoN'^[crh2*tW<{1U+l_QSncX<)Q(wJH ٯ#zCm>nhf6t}M&ʺ6ײ'\gkNS:;\qN-S;kǺ"{DailL`̗/޿ ^o#I&%0]SPV!] PK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 0_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!^}-theme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] R 117  L"%&"-r@0P^\l|fL *pԈ~d`"rj.FRVa>f^f579;=?ACEGIKMOQT &l-:J"Vb$r@f:az"&|bN@BDFHJLNPRSUT # @H 0(  0(  B S  ? %(FHstBC / 1 2 < Y [ f g x O S U H]^!"'(01<=EFLNUV\]fgtu{~!#:;AC*,;BNYho{ %+.38=>HRt{ .;=CDRT[\bw-3=FQVZ\qy  249:;IJO^h )=DP[^jkt~ "',-.7<GHR_dgrsy%'-.<>FGOdqsyz %2;FKOQfn 249:;IJOfknyz%+,3AHdoprsx|   "*+3HUW]^l   $ ) - / D L d g j p q y !! !!!"!#!$!2!3!8!Z!`!i!p!!!!!!!!!!!!!!!!" "'"3">"J"P"T"X"Y"c"d"p"r"{""""""""""""""""""""""""## ####/#0#5#6#>#?#F#L#W#X#Z#[#`#d#o#t#################$$ $$$$$"$$$%$0$5$@$A$K$W$\$g$p$$$$$$$$$$$$$$&&&&&&''"'7'B'C'E'F'K'O'Y'_'j'k'p''''''''''''''''''(((((!(&()(,(5(7(;(B(G(L(O(R(\(^(b(j(k(s(u(|(}(((((((((((((((((((((( ))))) )$)))+)B)C)I)J)))))))))))))***/*7*J*M*Q*U*V*\*o*|*}****************++ ++%+4+<+>+C+L+W+\+`+b+t+v+{+}+~+++++++++++++++++++9->-@-R-\--------------------..... .*.2.?.A.G.H.V.X.`.a.i.}.............../////%/+/7/@/K/P/T/V/k/s/w/}/~///////////////////00000-0/0406070D0E0J0X0d0w0000000001111111111222 2$272G2I2Q2]2j2k2s2z2222222222222222222223333#3$32343<3=3E3Z3g3i3o3p3~333333333333333344 44494>4B4D4Y4c4e4k4l4t44444444444444444 5 55'5)595;5C5O5\5]5e5l5w5x5z5{5555566666666666667&797D7E7G7H7M7Q7V7X7o7p7v7{77777777777777777777778!8#8)8*888U8]8j8t8v8z8{888888888888 99 9&9'9*9-9293999M9Z9[9c9u9{9~999999999999999999:::*:7:B:C:E:F:K:O:Y:Z:W;\;^;_;h;m;x;y;;;;;;;;;;;;;;;;;<<<<<$<*<7<@<A<D<E<O<V<c<e<k<l<z<|<<<<<<<<<<<<<<=== ==-=.=;=<=D=U=[=u=z================>> >>>9>>>B>D>V>X>]>_>`>n>o>t>y>>>>>>>>>>>>>>>>>>>???$?+?7?B?\?c?o?z??????????????????????????@ @ @ @@@%@&@0@?@K@i@t@u@w@x@}@@@@@@@@BBCCC3C5C:CIJLMRVabjk!#.56DTZ_jksy '(78@CTU\^cnvwßğ˟͟cejprsyz ǠΠݠߠΡաסܡ#24HPآڢߢ(./;<BHSTVW\crt/05:<=BCLMTYdeopxĤФѤޤߤ "#%&+.çħΧϧק $5@ACDIMWXĩũҩթߩ)0;<>?DQ¬ìЬӬݬެ '.9:<=BFPQglnotuŮͮήծ֮ܮۯ $GR^ijlmrv{}*+6KWcnoqrw{شݴߴ $%'(-168OPVW̷ͷҷ׷$*5689>BLMty{|¹ȹѹٹڹ߹ 239:˺ͺкѺȽսݽ "#chjtz{˿ӿ޿߿FKMOUV_fov|} *2 !(/:IQ[ituwx} $(-/56AI 5?MXY[\aejlrs~ &/0;=GU`acdimrtz{ !*1:@FGNPUZalqr~]cefkluzy~ &')*/38@KLSZOTVdrw !$)6:=@EGVW]d $1<JUVXY^bgixy46BC#&'1:?LTU]cnoqrw{ !BILUVcdjt~ '1=>GHMNT]dej%*4NW`gs|} %-4@IJQRXfpry "0:<Ckvw} ()/;ABEFST\bijvy !",-6<CDLPUbmz ",4<?ACHJQWdmvUWXZabdemnw&389@BGHOSbtz{%019;>?IJST^_hlo} &-189ELUV_cikrt{%(.0<>FHN]_dfgqr|}#,-2>GHPQZjtv MRS[]jlu !"+2:;BCLMRXcdfgloz{&09:?@JMVZ_ginpqy|%)/078AEQR]ltu{ !'(2JST`jrsyz %( @AABwx0 1 h i   Z [ P S m o 1<=Agtu{~78S[w|24NO&'oqrz24NO J O !!7!8!!!~""""""$$1$4$&&''K'M'['h(((((t+v+8-9-......q/v/-0/0I0J01122333333\4^44444446677m8o888999999V;W;;;3<6<<<= ===V>X>>?@@@@3C5CCCCDDD E EkHmHHHIIGJHJAMCM^M_MOOOO'R)RSSVV W WgWiWvWXXX[[E^F^^^ddhhheiSj\j kkakbkWpYpqqrrrrwwwwxyyyyy~~$Ӏ܀"#߅"#45BC9B12<EӜԜijǠɠơޢߢ\^ƣ45DF8=^_իګBDQafgstگۯͰа״شMOxystbcEF&(OQPm[]jkwyMOAC$&]_lm:;z{<=jk!':HsyX  S X 01{~;=?79;"*,.279; !"!$!""""$ $"$%$&&&&((((t+y+{+~+4-<->-A--02040P01111444466669999R;Z;\;_;V>[>]>`>?@ @ @B8C:C=CDDDD6HpHrHuHCJKJMJPJAMFMHMKMNOO OQ,R.R1RSSSTVVVVXXXX[\\\A^I^K^N^d d ddhhhh]kekgkjkWp]p_pbprrrrwwwwyyyy~~~~&(+ۅ>GIL-68;؜ڜݜ!$ enpڢ8:=bjlo֯ޯӴ۴ݴyowy|^fhkIKO)acfw|~MRTWAFHot]bdg ,glnkZ7>deAB1 1 Y [ P Q S \]0<g;=79*,79 !"!"" $"$&&((y+{+<->-204011446699Z;\;[>]>@ @8C:CDDpHrHKJMJFMHMOO,R.RSSVVXX\\I^K^ d dhhekgk]p_prrwwyy~~&(GI68؜ڜ!np8:jlޯ۴ݴwyfhIKac|~RTFHbd ln x$~y0s4CzE5ggnLd[5rT6 8zxw8# +/F.nuT"WLZQ9Tce4hY Bu>^`o(.^`.pL^p`L.@ ^@ `.^`.L^`L.^`.^`.PL^P`L.^`^`^`^`^`^`^`^`^`^`.^`.pL^p`L.@ ^@ `.^`.L^`L.^`.^`.PL^P`L.-^-`OJPJQJ^Jo(-^`OJQJ^Jo(hHo ^ `OJ QJ o(hH ^ `OJQJo(hHm^m`OJQJ^Jo(hHo=^=`OJ QJ o(hH ^ `OJQJo(hH^`OJQJ^Jo(hHo^`OJ QJ o(hHh ^`o(hHh ^`hH.h pL^p`LhH.h @ ^@ `hH.h ^`hH.h L^`LhH.h ^`hH.h ^`hH.h PL^P`LhH.h^`OJ QJ o(hHh^`OJQJ^Jo(hHohp^p`OJ QJ o(hHh@ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohP^P`OJ QJ o(hH^`.^`.pL^p`L.@ ^@ `.^`.L^`L.^`.^`.PL^P`L.^`56B* o(ph .^`.[ L^[ `L.+ ^+ `.^`.L^`L.^`.k^k`.;L^;`L.hh^h`^`.(0(^(`0..T0T^T`0... ^` ....   ^ ` .....  ` ^ `` ......  ` ^ ``....... hh^h`........h^h`.P^`P..^`...x^`x.... ^` .....  X^ `X ......  ^ `....... 8^`8........ `^``.........^`OJPJQJ^Jo(-h^h`OJQJ^Jo(o 8^8`OJ QJ o(  ^ `OJQJo( ^ `OJQJ^Jo(o ^`OJ QJ o( x^x`OJQJo(H^H`OJQJ^Jo(o ^`OJ QJ o(h ^`o(hHh ^`hH.h pL^p`LhH.h @ ^@ `hH.h ^`hH.h L^`LhH.h ^`hH.h ^`hH.h PL^P`LhH.h^`OJPJQJ^Jo(-h^`OJQJ^Jo(hHohp^p`OJ QJ o(hHh@ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohP^P`OJ QJ o(hH nuT +/F$~y BuTce5gd[5zxw84T6WLZC rv?X @"""""""" """""""""zr!pt"""""""""r""""""""J &}(~ZFn[*i"}#/!79`aekKt^g ); Ebr{uG 8$NTWhi+wznt+zJQgr I'>R  2<Nvux%_cvv.x :  75 <> P MQ_lm-YIeXY[bb ea&(PRTi },29Dd gst-;1gqr<9c1dnxy %(77=uQX 90;qF:Kye.ym  !(6xT O!]1Z78[HH*Mb'"- 0;tE%NNYsYYjxG hK!!06^d*=^|.@ ['3CQ!b-:\?UZ)n,9?vBHPi0w! )7;\pa z3 V 7W j !!%!E@!P!P![!b!\t! ""@>"'# ## "#D#JQ#V#(c#{#c$$9$$=$8$#I$o$v$w$|$$N% %*%'0%KT%e&*&|1&4&:9&k?&,D&DX&n&It&'t'(( ('(*(a*(+(),(U()>)%)5:)G)>S)f) *A"*A*B*:e*}n*t*w*+ +E2+?+zx+(,j.,x4,d,#-,-?-h-s- .{._..`0.[2.56.].dp.~p.1s.// /(/@/(I/i/k/y/ 0 0}q0"0Z 1S21?1~12)25282l2/3t<3 V3+[3h3&r3Bz3D4> 4 4$4/4o4v4Ry4b555o5.5b56tF6R6g6"s6ju6v6z6 }6p7e7 77D7e7l7C:8uM8W8de8Ik8w8?99'9!`9d9:>:3:4:P:!;&;=;B;B;*E;W;\;_;f;m;go;s;q};<: <,<0;< G<1T<Vo<|<=;=>>>F(>?Q>Hy>(? ? ?&?'?X6?/;?ZD?q?sw?@Q1@4@AA+A5A+6AiMBmhB!C]8CACUCeCU}C3D\3D]DsD4yDq EE,E3E~EvF_G&Gq+GtGHHH6H6HV:H4HHILI8RIvI J4J5JXJbJ KK 3K"CKhK`sKjuKwKayK LL*L0LaLjLuLTM?/MpGM$HMSWMaMuMW-N=N'XN# O *O-O-GOHOOO+OO\nOnOPm PCPdP1P2P4PZPqP,}P~PQzMQSQzQRR&R.RB:RaR^SoFSKSlSTTTTa3TLTMTPTkTUUAU9UpPUPUfgUAoUuUyU' V>V%NVANVNV-\VDfVn%W*W-W0W*c[coc|cRddd/d4dUd ee?eCeGePe Weoe7pe?ffI*fk/fhfpfSuf'gJgNg\gvbgjghQh =hFh{Lh(i]i-ci'dijf jj)j_3j8j^Xjfk kk*k,k4>kT^klcl4AlHlglllmTm`mim`jmXnnF*n;n>n-o o*ouowo{otp[pEpqTMqpqcrGfr=krrrsss*s+s@sOAses*sttt*t-tt"LtUt|tup/uc;uBuUuZupusuvu|u7vv2 v0vi2vBbgnt9#:(I,=O:V`aAd%1u9BISXBa;- D&sFjp*l&4-x1:GRYm8 Sb !&7JrrtT 1[xkl&L (.I>Do7RYVdhh I(@IhpvU*k0[b}0M2[=dUqT!Dhx#NkxyePhs(+#Vdg 2ADQN&,Q5fNP-Z8`]psoJl )ZD ksMsCWeqC|/4AP,Q@7m@E6l3!.NV7Zr3uz2|X*9]^aqz=>xE]m or; @RSas|UJp 2: B&I4,.&Xk]3<*>pFHML&Zefvlb27CGH'7%9Ib'O$-@CJs .AQ Q$%(7BVYl{{z9 \0SKZ h#66eEMj`M}Vp]dtEvTxu R@(>+?5FJFPSSg 9ZboxYl(C\djo.Z I2Ie. i(Mf%e78m?pBWy14ciyj#C{}szV-n3Tisz|~0O"WW[npNWMu&w =mDEWP^e[nez Z$<gi| JVY9^$ AK{>X{+~?yNVzoy!_{P`$33ju_3f:?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXZ[\]^_`bcdefghopsRoot Entry FTX[ur@Data W1TablemWordDocument qSummaryInformation(YDocumentSummaryInformation8aMsoDataStoreC[uPR[uFZRJCJE00YUDQ==2C[uPR[uItem  PropertiesUCompObj r   F Microsoft Word 97-2003 MSWordDocWord.Document.89q